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Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia, but knowledge of
the arrhythmogenic substrate is incomplete. Alternans, the beat-to-beat alternation
in cardiac electrical signals, typically occurs at fast heart rates and can sometimes
lead to arrhythmia. Atrial alternans has been observed at slow pacing rates in car-
dioverted AF patients, suggesting that alternans may play an important role in the
arrhythmogenic substrate of AF. The mechanisms underlying alternans in patients at
slow pacing rates, and the contribution of atrial alternans to arrhythmogenesis, are
currently unknown.
In order to address these gaps in understanding, a computational approach was
used to elucidate the cellular mechanisms underlying alternans and to assess the ef-
fects of alternans on arrhythmogenesis in the atria. Simulations revealed that reduced
ryanodine receptor (RyR2) inactivation, resulting in a steep sarcoplasmic reticulum
(SR) Ca2+ release-load relationship, was responsible for alternans at slower pacing
rates. The effect of these Ca2+-driven alternans (CDA) on arrhythmogenesis was
explored using an anatomically realistic, 3D model of the human atria. It was found
ii
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that CDA significantly increased the vulnerability of the atria to arrhythmia. Fur-
thermore, CDA was found to promote arrhythmia maintenance through frequent
wavebreak, which led to increased arrhythmia complexity and scroll wave persistence.
Thus, these findings suggest that disrupted SR Ca2+ release in the atria is linked to
arrhythmogenesis via the influence of alternans.
This research provides a rationale for new mechanistic therapies for AF, suggesting
that targeting RyR2s may be an effective antiarrhythmic strategy. Incorporation of
these findings into future models may aid in the development of better treatment
strategies for AF.
Primary Reader: Natalia A. Trayanova, Ph.D.
Secondary Reader: Feilim Mac Gabhann, Ph.D.
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The heart is responsible for pumping blood to deliver oxygen and nutrients to
the body. The heart muscle (myocardium) is composed of a network of electrically
coupled excitable cells (cardiomyocytes), which are organized into fibers and laminar
sheets. Electrical signals control mechanical contraction of the heart, and the orderly
conduction of electricity through the cardiac syncytium is central to the heart’s func-
tion. Under normal circumstances, contraction (systole) is initiated by an electrical
signal from the sinoatrial node (SAN). This electrical signal propagates through the
right atrium (RA) and left atrium (LA), the upper chambers of the heart, causing
them to contract. The ventricles, the lower chambers of the heart, are separated
from the atria by nonconductive fibrous tissue. During atrial systole, the ventricles
1
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are in diastole (relaxed), and contraction of the atria helps to fill the ventricles with
blood. Conduction of electricity from the atria to the ventricles occurs through the
atrioventricular node (AVN) and the bundle of His. At the AVN, conduction slows
to allow proper timing of contraction between the atria and ventricles. The bundle of
His then carries the electrical signal across the fibrous tissue to the Purkinje fibers, a
specialized network of cells which rapidly conducts electrical signals to the ventricles.
This results in the synchronized contraction of both the right ventricle (RV) and left
ventricle (LV), which pump blood to the lungs and body, respectively. After ejecting
blood, the myocardium returns to diastole until the next beat is initiated from the
SAN.
1.1.1 Cardiac Action Potentials
The electrical signals in the heart are known as action potentials (APs). An AP is
the characteristic depolarization and repolarization of the excitable membrane (sar-
colemma) of a cardiomyocyte. During an AP, voltage-gated ion channels located in
the sarcolemma open in response to changes in membrane polarization, allowing con-
centration gradients to drive ions across the membrane. This ionic current flow in turn
changes the polarization of the sarcolemma, which acts as a capacitor. The voltage
across the sarcolemma is known as the transmembrane potential (Vm). Cardiomy-
ocytes are electrically coupled through low-resistance intercellular channels called gap
junctions, which allow APs to propagate and excite neighboring cells.
2
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Figure 1.1: Currents that underlie the mammalian cardiac AP1
Schematic of the depolarizing and repolarizing currents that underlie the action
potential (AP) in the mammalian ventricle. A control (solid line) and failing
(dotted line) AP profile are shown in the center. The phases of the AP are
labeled. A schematic of the time course of each of the currents is shown as well
as the gene product that underlies the current.
Ventricular and atrial myocytes undergo five phases during an AP (Fig. 1.1). Dur-
ing the resting phase (phase 4), the inward rectifier K+ current (IK1) maintains Vm
at a resting potential near −80 mV. When an initiating stimulus raises Vm above the
threshold potential (around −40 mV), fast Na+ channels activate and Na+ flows from
the extracellular space into the cell, resulting in the rapid depolarization of the mem-
brane (the upstroke, phase 0). During phase 1, the fast Na+ channels inactivate and
1Reprinted from G. Tomaselli, “Electrophysiological remodeling in hypertrophy and heart fail-
ure,” Cardiovascular Research, vol. 42, no. 2, pp. 270–283, may 1999, by permission of Oxford
University Press.
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transient outward K+ channels activate, resulting in outward flow of K+ and a brief
repolarization period (the “notch” in the AP). During phase 2, transient outward K+
channels close, and L-type Ca2+ channels and delayed rectifier K+ channels activate.
The inward Ca2+ current and the outward current K+ carried are balanced, so Vm
does not change significantly during phase 2 (the plateau phase). During phase 3,
the L-type Ca2+ channels inactivate and the delayed rectifier K+ current repolarizes
the membrane. As Vm returns to rest, the delayed rectifier K
+ channels close, and
IK1 dominates again in phase 4.
Action potential duration (APD) is the span of time between the AP upstroke
(phase 0) and repolarization (phase 3). APD can be quantified at different levels of
repolarization. For example, APD90 refers to the duration between phase 0 and 90%
repolarization of Vm.
1.1.2 Excitation–Contraction Coupling
An AP triggers the cardiomyocyte to shorten in a process known as excitation–
contraction (EC) coupling (Fig. 1.2). The AP is coupled to the mechanical contrac-
tion of the myocyte via Ca2+. Critical to this process are structures called T-tubules,
which are invaginations in the sarcolemma that carry the electrical signal into the
central regions of the cardiomyocyte. Ca2+ signaling occurs in the narrow junction
between the sarcolemma of the T-tubules and the sarcoplasmic reticulum (SR) mem-
brane. When the membrane depolarizes during an AP and the voltage-gated L-type
4
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Figure 1.2: Ca2+ transport in ventricular myocytes2
Inset shows the time course of an action potential (AP), Ca2+ transient (CaT),
and contraction measured in a rabbit ventricular myocyte at 37 °C. NCX,
Na+/Ca2+ exchanger; ATP, ATPase; PLB, phospholamban; SR, sarcoplasmic
reticulum.
Ca2+ channels open, Ca2+ flows from the extracellular space in the T-tubules to the
junctional space (also known as the diad). Ca2+ in the diad binds to ryanodine re-
ceptors (RyR2s), ion channels located in the SR membrane, triggering them to open
and release Ca2+ stored in the SR—a process known as Ca2+-induced Ca2+ release
(CICR). Ca2+ also binds to and inactivates L-type Ca2+ channels in the diad. Ca2+
then diffuses out of the diad into the cytosol, where it binds to myofilaments, allowing
the thin and thick filaments to slide against each other and contract the cell. During
2Reprinted by permission from Macmillan Publishers Ltd: D. M. Bers, “Cardiac excitation–
contraction coupling,” Nature, vol. 415, no. 6868, pp. 198–205, jan 2002.
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relaxation, as Ca2+ dissociates from the myofilaments, it is pumped back into the SR
by the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), and it is extruded from
the cell by the Na+/Ca2+ exchanger (NCX). A small amount of Ca2+ is also extruded
by the sarcolemmal Ca2+-ATPase. Calsequestrin (CSQN) binds Ca2+ in the SR and
helps to store Ca2+ at very high concentrations.
1.1.3 Arrhythmogenesis
Cardiac arrhythmias are disruptions in the normal pattern of electrical propaga-
tion in the heart. They can occur when the heartbeat is too fast (tachyarrhythmias)
or too slow (bradyarrhythmias). Tachyarrhythmias may arise from triggered (ectopic)
beats originating outside the SAN, or from what is known as reentry. Reentry occurs
when a wave encounters conduction block and is able to propagate around the area
of block, eventually re-exciting the previously refractory tissue where block occurred.
Reentry persists as long as there is excitable tissue along the direction of propagation.
Hence, wavelength (the distance traveled by the electrical impulse during one refrac-
tory period) is a critical determinant of reentry vulnerability, since the wavelength
must always be shorter than the reentrant circuit. Reduced conduction velocity (CV)
and shortened APD both decrease wavelength and thus promote reentry.
Reentry can be either anatomical or functional. In anatomical reentry, a physical
obstacle such as fibrotic scar tissue anchors the reentry, which propagates around the
non-conducting obstacle (Fig. 1.3A). In functional reentry, all tissue is excitable, but
6
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Figure 1.3: Reentry and arrhythmia
Cardiac tissue with propagating electrical waves (light green), wavefronts (green),
wavebacks (black), and filaments (pink). A. 2D view of anatomical reentry an-
chored by a non-conducting obstacle (gray circle). B. 2D view of functional
reentry rotating around an unexcited core region (dotted gray circle). C. 3D
view of a single scroll wave. D. 3D view of multiple wavelets.
there is a small core region of unexcited tissue around which a scroll wave rotates
(Fig. 1.3B). A vortex filament is the organizing center of the scroll wave, located at
its tip where the wavefront meets the waveback. Both anatomical and functional
reentry require spatial heterogeneity to occur. In the case of functional reentry, this
arises from differences in excitability, refractoriness, or tissue structure.
Many tachyarrhythmias are characterized by a single scroll wave or reentrant
7
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circuit (Fig. 1.3C). These can degrade into fibrillation, the most severe form of tach-
yarrhythmia, when a single wave breaks up into multiple scroll waves or wavelets
(Fig. 1.3D). The number of vortex filaments present is thus an indicator of the com-
plexity of the arrhythmia. During fibrillation, the heart is unable to pump blood due
to the disorganized electrical activity in the myocardium.
1.1.4 Cardiac Alternans
Alternans is the beat-to-beat alternation in cardiac electrical signals. Alternans
can occur at the cellular level, driven by refractoriness of cellular ionic currents, and at
the tissue level, driven by conduction refractoriness. At the cellular level, alternans in
Vm (such as APD alternans) and alternans in ion concentration usually occur together
due to the fact that they are bidirectionally coupled via electrogenic transmembrane
currents. Because intracellular Ca2+ concentration ([Ca2+]i) varies over a wide range
during EC coupling, Vm is often closely coupled to changes in [Ca
2+]i. The primary
driver of cellular alternans can be either voltage or Ca2+ mechanisms.
Alternans can promote arrhythmia by increasing repolarization dispersion in the
myocardium, leading to increased wave breakup and reentry [3]. Alternans has been
observed in the ventricles of heart failure patients and has been linked to increased
arrhythmia susceptibility [4, 5].
1.1.4.1 Voltage-Driven Alternans
8
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Figure 1.4: APD restitution and alternans3
Cobweb diagram of APD alternans arising from steep APD restitution slope,
after Ref. [6]. Blue line shows the APD restitution curve, and red line shows
the CL=APD+DI line. The top graph illustrates the effects of a perturbation,
which shortens DI (asterisk), displacing the system from its unstable equilibrium
point (solid black circle at the intersection of the two lines), resulting in persistent
APD alternans, as shown in the bottom trace.
APD restitution is the relationship between APD and the preceding diastolic
interval (DI). The shape of the APD restitution curve reflects the recovery of the
various inward and outward currents that generate the AP. APD typically decreases
as DI decreases. When the cell is paced at a fixed rate, the relationship between APD
and the following DI is determined by the pacing cycle length (CL). The intersection
3Reprinted from J. N. Weiss, A. Karma, Y. Shiferaw, P. S. Chen, A. Garfinkel, and Z. Qu,
“From pulsus to pulseless: The saga of cardiac alternans,” Circulation Research, vol. 98, no. 10, pp.
1244–1253, may 2006, by permission from Wolters Kluwer.
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of the APD restitution curve and the pacing CL curve determines the operating point
of the system. One can apply fixed point stability analysis to understand the limiting
behavior of the system described by the APD restitution curve (Fig. 1.4). APD on
the current beat determines APD on subsequent beats through an iterative mapping
between the APD restitution function and the pacing CL function. At any given
pacing rate, the fixed point is stable if the slope of the restitution curve at the fixed
point is <1. At fast pacing rates, the slope of the restitution curve is usually >1, and
APD alternans occurs as a result of persisting oscillations around the fixed point.
1.1.4.2 Calcium-Driven Alternans
During EC coupling, Ca2+ cycles between the extracellular space and intracellu-
lar and SR compartments. The stability of Ca2+ cycling depends upon the recovery
of these different fluxes from beat to beat. When one or more components of Ca2+
cycling lags behind on a given beat, this results in changes in the amplitude and/or
duration of the intracellular Ca2+ transient (CaT). This in turn impacts the subse-
quent CaT, leading to alternation analogous to that occurring in Vm due to steep
APD restitution. These Ca2+-driven alternans (CDA) depend upon many different
factors. Since the CaT is primarily composed of Ca2+ released from the SR, two
major determinants of Ca2+ cycling stability are SR Ca2+ uptake efficiency and SR
Ca2+ release. SR Ca2+ uptake efficiency determines how quickly SERCA can restore
SR load (the amount of Ca2+ in the SR) during diastole. SR Ca2+ release changes as
10
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a function of the amount of trigger Ca2+ (Ca2+ influx through L-type Ca2+ channels)
and SR load. SR Ca2+ release can also depend upon refractoriness of RyR2s [8].
CaT alternans couple to Vm via sarcolemmal Ca
2+ currents. A large CaT results in
increased Ca2+ extrusion by NCX, which exchanges three Na+ for one Ca2+, generat-
ing a net inward current. Inward NCX current (INCX) depolarizes the membrane and
causes APD prolongation. On the other hand, a large CaT also results in increased
Ca2+-dependent inactivation of L-type Ca2+ current (ICaL), which promotes APD
shortening. These relations are reversed during the small CaT. Whether the large
CaT produces APD prolongation (positive coupling) or APD shortening (negative
coupling) depends on the relative balance of INCX and ICaL.
1.1.4.3 Conduction Alternans
CV in the myocardium depends on tissue structure, the number of gap junctions
between cells, and fast Na+ current (INa) availability. At faster pacing rates, INa
has less time to recover from inactivation, so fewer channels are available to elicit an
AP, resulting in slowed propagation. CV restitution describes how CV changes as a
function of the preceding DI. When the slope of the CV restitution curve is steep,
CV alternans occurs. Variation in CV impacts the effective CL experienced by tissue
distant from the pacing site. During slow conduction, the propagating wavefront
takes longer to reach distant sites, so these sites experience a longer CL and a longer
DI. During fast conduction, the inverse is true. In tissue, therefore, the effects of APD
11
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restitution and Ca2+ cycling restitution are tied to the effects of CV restitution. At
fast pacing rates, these interactions can result in discordant alternans, when different
regions of tissue alternate out of phase with each other [9]. The regions of positive and
negative phase are separated by nodal lines or surfaces, where alternans magnitude
is zero.
1.2 Atrial Fibrillation
Atrial fibrillation (AF) is currently the most common sustained arrhythmia and
is associated with significant morbidity and mortality, constituting a major public
health concern [10]. Advances in the treatment and prevention of AF are needed
to address its rising global prevalence and incidence in the coming decades. Ther-
apies which directly target the mechanistic basis of AF in individual patients are
currently lacking [11, 12]. Progress in AF treatment will depend upon advances in
our understanding of the various mechanisms that underlie atrial arrhythmogenesis.
1.2.1 AF Mechanisms
AF is initiated by ectopic activity, oftentimes arising from the pulmonary veins
(PVs). Ectopic activity occurs due to abnormal automaticity, early afterdepolariza-
tions (EADs), or delayed afterdepolarizations (DADs). DADs in particular play an
important role in AF initiation [13]. Ca2+ overloading due to atrial tachycardia leads
12
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to an increase in spontaneous Ca2+ release during diastole, which is then extruded by
NCX. DADs, the depolarizing currents generated by NCX, can trigger an AP if Vm
rises above the threshold potential, promoting arrhythmia through rapid focal dis-
charge or interaction with a vulnerable substrate. Upregulation of INCX in response
to Ca2+ overloading worsens the situation, as it increases the likelihood of DADs
triggering an AP [14].
Atrial tachycardia promotes the development of a vulnerable substrate by inducing
electrical and structural remodeling of the atria. Downregulation of ICaL and upreg-
ulation of K+ currents result in APD shortening. Reduced INa and gap junctional
coupling and increased interstitial fibrosis result in decreased CV. These changes pro-
mote AF by decreasing wavelength and allowing the atria to sustain more reentrant
circuits [15]. The remodeling which promotes AF is in turn further induced by AF,
leading to an increase in AF frequency and duration—thus the notion that “AF begets
AF”. Clinically, this occurs as a progression from paroxysmal AF (lasting <7 days)
to persistent or chronic AF (lasting ≥7 days) and finally to permanent AF.
1.2.2 AF Treatment
AF is treated with anticoagulants (to decrease the risk of stroke due to AF)
and rate- or rhythm-control medications and interventions [11]. Rate control aims
to reduce the frequency of ventricular activation during AF by targeting the AVN
but does not address the abnormal rhythm within the atria. Rhythm control of the
13
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atria can be attempted either pharmacologically or with catheter ablation. However,
antiarrhythmic drugs used to treat AF can oftentimes promote arrhythmia in the
ventricles. Catheter ablation is used to treat paroxysmal and persistent AF, through
PV isolation and/or targeting of reentrant drivers, but the success of catheter ablation
treatment is low for patients with longer-duration AF [16].
1.2.3 Alternans and AF
Clinical evidence suggests that atrial alternans may also play a role in the initiation
of AF. APD alternans have been observed in the atria of cardioverted AF patients
at slower pacing rates as compared to controls [17]. Narayan et al. reported that
alternans always occurred before AF was induced at fast pacing rates [18]. Thus,
the authors hypothesized that alternans may be an important clinical marker for AF
risk. However, whether atrial alternans observed in patients play a significant role
in arrhythmogenesis, and whether the underlying cause of alternans might present a
promising target for novel therapies, is currently unknown.
1.3 Objectives
The goal of this research was to elucidate the mechanisms underlying alternans
observed during atrial pacing in AF patients, and to determine the arrhythmogenic
implications of such alternans at the organ scale. The specific aims of this work were:
14
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• Specific Aim 1: Identify the cellular mechanisms responsible for the onset of
APD alternans at slow pacing rates using computer models of human atrial
tissue and cells.
• Specific Aim 2: Evaluate the effect of elevated alternans propensity on arrhyth-
mia vulnerability due to ectopic beats in an anatomically realistic human atria
model.
• Specific Aim 3: Assess differences in arrhythmia complexity and persistence due





Mathematical modeling enables the study of cardiac electrophysiology at high
spatiotemporal resolution. By integrating the complex interactions that occur at
multiple scales of biology, computer simulations enhance our understanding of normal
cardiac function and disease mechanisms. Cardiac modeling has a rich history and has
undergone major advances in recent years [19]. The basic principles and techniques
involved in cardiac modeling are outlined in the following sections.
2.1.1 Cell Membrane Kinetics
Hodgkin and Huxley pioneered the first mathematical model of an excitable cell
membrane in 1952 [20]. In their model of the squid giant axon membrane, total
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+ Iion + Itrans (2.1)
Im is the total membrane current density, Cm is the membrane capacitance per unit
area, Vm is the transmembrane potential, Iion is the ionic current density, and Itrans
is the current density of a transmembrane stimulus. Iion is composed of fast Na
+
current (INa), delayed rectifier K
+ current (IKr), and a background leak current (Il).
The ionic conductances of INa and IKr depend on gating variables whose opening and
closing rates are functions of transmembrane potential (Vm). Hodgkin and Huxley’s
formulation of these currents was based on detailed experimental measurements using
voltage clamping. When integrated numerically, their equations could accurately
recapitulate action potentials (APs) in the squid giant axon.
The first model of a cardiac AP, developed by Denis Noble in 1962, was based on
this Hodgkin-Huxley formalism [21]. The model included modifications of Hodgkin
and Huxley’s original equations and the addition of inward rectifier K+ current (IK1).
Since then, as more experimental data has become available, cardiac AP models have
been updated considerably to reflect the composition and kinetics of ionic currents in
the heart [22]. These include L-type Ca2+ current (ICaL), Na
+/Ca2+ exchanger (NCX)
current (INCX), Na
+/K+ pump current (INaK), and transient outward K
+ current
(Ito). There are now a multitude of models available based on different animal species
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and human data, as well as different cell types within the heart.
2.1.2 Modeling Calcium Handling
During a cardiac AP, cellular Ca2+ content changes as a result of ICaL and INCX .
Within the cardiomyocyte, Ca2+ cycles between the diad (junction), the sarcoplasmic
reticulum (SR), and the cytoplasm. Cardiac AP models generally represent these
as separate lumped compartments within the cell, each with its own distinct Ca2+
concentration and distribution of ionic currents. Some earlier models do not include
representation of the diadic space. The SR may be further subdivided into junctional
and network compartments, and the intracellular space may be subdivided into sub-
sarcolemmal and cytosolic compartments. Simple diffusion of Ca2+ occurs between
compartments not separated by membranes, and movement into and out of the SR
occurs through ryanodine receptor (RyR2) and sarco/endoplasmic reticulum Ca2+-
ATPase (SERCA) fluxes.
2.1.3 Bidomain Representation
The bidomain equations treat the cardiac syncytium as two continuous conducting
mediums that represent the intracellular and interstitial spaces [23]. Current flow
within each domain depends on the intracellular and extracellular conductivity tensors
(σ̄i and σ̄e, respectively), which are anisotropic due to the fiber and laminar sheet
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structure of the myocardium. Current flow between the domains is governed by Im
(see Eq. 2.1):
∇ · σ̄i∇ϕi = βIm (2.2)
∇ · σ̄e∇ϕe = −βIm − Ie (2.3)
Vm = ϕi − ϕe (2.4)
ϕi and ϕe are the intracellular and extracellular potentials, respectively, β is the cellu-
lar surface-to-volume ratio, and Ie is the current density of an extracellular stimulus.
The bidomain model assumes that there are no current sources or sinks in either
domain and that no charge accumulation occurs at any point. An extracellular bath
with conductivity σb may also be considered:
∇ · σb∇ϕe = Ie (2.5)
The extracellular domain is assumed to be continuous with any surrounding bath,
and no current flux occurs at the boundaries of the intracellular and extracellular
domains. If the extracellular field is not being considered, or if the ratio of σ̄i to
σ̄e is constant, then the bidomain equations can be simplified to the monodomain
equation:
∇ · σ̄m∇Vm = βIm (2.6)
where σ̄m is the monodomain conductivity tensor.
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2.2 Finite Element Method
The bidomain equations can be solved numerically using a finite element approach.
Tissue or organ geometry is discretized into a mesh composed of 3D elements con-
nected at points called nodes. Fiber orientation is defined for each element, which
determines σ̄i and σ̄e (or σ̄m in the case of the monodomain equation). Vm, ϕe, and Im
are defined at every node (Vm and Im only in monodomain), and equations are solved
over each element. The bidomain equations are decoupled into a set of ordinary dif-
ferential equations (Eq. 2.1), a parabolic partial differential equation (PDE) (Eq. 2.7),
and an elliptic PDE (Eq. 2.8), which can be solved together by leapfrogging [24].
∇ · σ̄i∇Vm = −∇ · σ̄i∇ϕe + βIm (2.7)
∇ · (σ̄i + σ̄e)∇ϕe = −∇ · σ̄i∇Vm − Ie (2.8)
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Disrupted calcium release as a
mechanism for atrial alternans
This study has been published in PLoS Computational Biology [25].
3.1 Introduction
Atrial fibrillation (AF) is currently the most common cardiac rhythm disorder,
posing a significant medical and economic challenge for the U.S. health care sys-
tem [26, 27]. This burden is likely to increase as the population ages and AF preva-
lence rises [28]. Effective prevention and treatment of AF depends upon advances
in our understanding of underlying disease mechanisms. Although several features of
AF electrophysiological remodeling have been identified over the past decades [15,29],
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our knowledge about the arrhythmogenic substrate remains incomplete.
Beat-to-beat alternation in the shape of cardiac electrical signals, a phenomenon
called alternans, has been observed in the atria of patients who experience AF, but
the mechanism underlying the alternans is not known [17, 18, 30–32]. Narayan et
al. reported differences in the rate dependence of action potential duration (APD)
alternans in patients, with APD alternans occurring at pacing rates near rest in AF
patients but only at fast pacing rates in controls [18]. Narayan et al. also found
that APD alternans always preceded AF initiation, indicating that alternans may
play an important role in establishing the arrhythmogenic substrate and creating
vulnerability to AF. Thus, a better understanding of AF arrhythmogenesis will likely
depend upon identification of the mechanism driving atrial alternans at heart rates
near rest.
Interestingly, in AF patients the slope of the APD restitution curve was <1 during
APD alternans onset at slow pacing rates. This suggests that a cellular mechanism
other than voltage-driven instability underlies APD alternans at heart rates near
rest [17]. Altered Ca2+ handling in atrial myocytes is known to play a crucial role in
the generation of AF triggers and in AF maintenance [33,34]. Ca2+ cycling instabil-
ities have been shown to underlie ventricular alternans in heart failure [5,35], as well
as atrial alternans in several non-AF animal models [36–38]. However, it is unknown
whether these represent a plausible mechanism for atrial alternans in AF patients,
particularly at heart rates near rest. We therefore sought to determine, using a com-
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puter model of human atrial tissue, whether Ca2+ handling abnormalities, or other
electrophysiological changes that occur in AF, lead to APD alternans. We identified a
critical change in the kinetics of the ryanodine receptor (RyR2) that was responsible
for APD alternans onset at slower pacing rates, and subsequently aimed to elucidate
the mechanistic relationship between this disruption in RyR2 kinetics and alternans
onset. To this end, we employed single-cell clamping of ionic model parameters and it-
erated map analysis in order to dissect the mechanisms which drive alternans in atrial
tissue, as well as to provide important insights into the pathophysiological changes
that contribute to the development of alternans in AF patients.
3.2 Methods
3.2.1 Human AF tissue model
In order to investigate ionic mechanisms in human AF that contribute to the gen-
eration of atrial alternans at the tissue level, we created a computer model of human
atrial tissue incorporating ionic remodeling associated with chronic AF (cAF). The
atrial tissue preparation had dimensions of 0.33 mm× 0.33 mm× 9.9 mm (Fig. 3.1A),
similar to the one used by Krummen et al. [39]. Human atrial cell membrane kinetics
were represented by a modified version of the Grandi-Pandit-Voigt (GPV) human
atrial action potential (AP) model [40], which we refer to as the GPVm model. De-
tailed explanation and justification of the GPVm model modifications are provided
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in the supplement (Section 3.5.1.1). Different types of human atrial tissue were mod-
eled individually as homogeneous tissue preparations, with each incorporating ionic
changes appropriate for each tissue type. Both control and cAF-remodeled tissue, as
well as left and right atrial tissue, were modeled using the parameter changes specified
by Grandi et al. [40] (see Section 3.5.1.2). The isotropic bulk conductivity value for
the tissue was tuned to produce a conduction velocity (CV) of 0.62 m/s in control
tissue [41,42]. When cAF ionic remodeling was incorporated, the same bulk conduc-
tivity value produced a CV of 0.59 m/s. These values are within the reported ranges
for control and AF CVs [43].
3.2.2 Protocols for evaluating alternans in the
human AF tissue model
We assessed alternans in the human AF tissue model by applying the clinical
pacing protocol used by Narayan et al. to induce alternans in AF patients [18].
The tissue model was first initialized at all nodes with steady-state values from a
single cell paced at 750-ms cycle length (CL). The tissue was then paced from the
stimulus electrode (Fig. 3.1A) for 20 beats at 750-ms CL and then for 74 beats at each
subsequent CL, starting from 500 ms and shortened in 50-ms steps to 300 ms, and
then shortened in 10-ms steps, until loss of capture or conduction block occurred.
Voltage traces from the recording electrode (Fig. 3.1A) were analyzed for APD
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alternans. APD was calculated as the time from maximal upstroke velocity to 90%
repolarization of transmembrane potential (Vm) from phase 2 amplitude. Alternans
magnitude was quantified as the mean magnitude of change in APD over the last
10 pairs of beats (11 beats total). APD alternans normalized magnitude (ANM),
obtained by dividing the alternans magnitude by the mean APD over the last 10
beats, was used to compare alternans between cells of varying APD. Alternans onset
CL was defined as the longest CL for which ANM was greater than 5% [18].
3.2.3 Sensitivity of alternans to ionic model
parameters
To identify cellular changes which could account for the onset of alternans in AF
patients at CLs of 300 ms to 500 ms [18], we explored how ANM varied in human
AF tissue models of both the left atrium (LA) and right atrium (RA) as a result of
changes in ionic model parameters. Of the 20 ionic model parameters tested, 10 were
parameters altered in the GPVm model to represent cAF [40]; others were associated
with L-type Ca2+ current (ICaL), delayed rectifier K
+ current (IKr), sarcoplasmic
reticulum (SR) uptake, or SR release (Table 3.1). We scaled parameter values one at
a time to between 25% to 200% of the default LA or RA values specified by Grandi
et al. [40]; for each parameter value within this range, simulations were conducted to
determine the presence of alternans (282 simulations total). In AF patients, average
25
CHAPTER 3. DISRUPTED CALCIUM RELEASE
alternans onset CL was >300 ms [18], so pacing and alternans analysis was restricted
to CLs≥ 300 ms.
3.2.4 Clamping protocols
After identifying conditions under which APD alternans magnitude and onset CL
matched clinical observations, we utilized two different clamping approaches in order
to investigate the key cellular properties that gave rise to the alternans, as described
below. Further explanation of the rationale behind these methods can be found in
Section 3.3.
3.2.4.1 Ionic model variable clamps
To determine which human atrial ionic model variables drive the occurrence of al-
ternans, we clamped individual ion currents and state variables in a single-cell model
paced at a CL exhibiting alternans [35]. A model variable was clamped to its steady-
state even or odd beat trace for the duration of 50 beats. This procedure was repeated
for different model variables (membrane currents, SR fluxes, and all state variables
excluding buffer concentrations), and APD alternans magnitude was quantified at the
end of the 50 clamped beats. Additionally, the magnitude of alternans in ∆[Ca2+]i
was quantified in the same manner as APD alternans magnitude, with ∆[Ca2+]i calcu-
lated as the difference between peak intracellular Ca2+ concentration ([Ca2+]i) during
the beat and minimum [Ca2+]i during the preceding diastolic interval (DI). Model
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variables were considered critical for alternans if clamping them to either the even
or odd beat reduced both APD and Ca2+ transient (CaT) alternans magnitudes by
>99% of baseline [35].
3.2.4.2 Action potential clamp
To evaluate the Ca2+ cycling properties of the human atrial cell model under dif-
ferent pacing rates and parameter values, the following equation was used to clamp Vm
to a generic atrial AP-like waveform so that comparisons between different conditions






(Vrest − Vmax) nCL ≤ t < nCL + APD
Vrest nCL + APD ≤ t < (n+ 1)CL
(3.1)
This approach has been used previously to investigate Ca2+ cycling properties in
ventricular myocyte models [44, 45]. We set Vmax=10 mV, Vrest=−75 mV, and
APD=200 ms. CL ranged from 200 ms to 700 ms.
The AP clamp enabled evaluation of Ca2+ cycling stability in the human atrial
cell model via an iterated map analysis [7,44,46]. We used a similar approach as Qu
et al. [47], where SR load and total Ca2+ content of the cell are tracked from beat
to beat. In our analysis, Ca2+ cycling stability depended upon three iterated map
parameters: SR Ca2+ release slope (m), SR Ca2+ uptake factor (u), and cellular Ca2+
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efflux factor (κ). A detailed derivation of the iterated map stability criteria can be
found in Section 3.5.1.4.
To compute the iterated map parameters, a single atrial cell was repeatedly
clamped to the AP waveform until model variables reached steady state. Follow-
ing this, SR Ca2+ concentration ([Ca2+]SR) was perturbed by ±1% at the beginning
of an even beat, and total SR load, release, uptake, and cellular Ca2+ efflux per beat
were recorded for the following 10 beats. For the Sato-Bers model, the first beat was
excluded since it deviated noticeably from the linear response of later beats. This
procedure was repeated starting with an odd beat so that data from a total of 40
beats were recorded (36 beats for the Sato-Bers model). Lastly, m, u, and κ were
computed as the slopes of the linear least-squares fit of the data (see Section 3.5.1.4).
3.2.5 Numerical methods
Monodomain and ionic model equations were solved using the Cardiac Arrhythmia
Research Package (CARP; Cardiosolv, LLC) [23]. Details on the numerical techniques
used by CARP have been described previously [24,48]. A time step of 20 µs was used
for all simulations.
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Figure 3.1: Human atrial tissue model
Tissue preparation setup and comparisons of control, cAF, and cAFalt tissue dur-
ing pacing. A. Atrial tissue mesh with stimulus and recording electrodes. B. APD
restitution curves for control tissue (black), cAF-remodeled tissue [40] (red), and
cAFalt tissue with APD alternans onset and amplitude matching clinical data [18]
(dotted red line). kiCa was reduced 50% in the cAF model to create the cAFalt
model. Action potentials (C) and Ca2+ transients (D) recorded from the last two
beats at 400 ms pacing CL. Alternans is present in the cAFalt tissue but not in
control or cAF tissue.
3.3 Results
3.3.1 APD alternans in the human AF tissue model
The human atrial tissue model described in Section 3.2.1 was used to investigate
ionic model parameters that contribute to the generation of atrial APD alternans
at the tissue level. The sensitivity of APD alternans to 20 ionic model parameters
(Table 3.1) was evaluated by varying parameters one at a time from LA cAF val-
29
CHAPTER 3. DISRUPTED CALCIUM RELEASE
ues [40] and applying the clinical pacing protocol used by Narayan et al. to induce
APD alternans in AF patients [18] (see Section 3.2.2). For control, a model of normal
human atrial tissue was also simulated. We then assessed the magnitude and onset
pacing CL of APD alternans by analyzing voltage traces from the recording electrode
(Fig. 3.1A), as outlined in Section 3.2.2.
In the control model, significant APD alternans did not occur before loss of cap-
ture at 260-ms CL (Fig. 3.1B). However, in the cAF-remodeled tissue preparation,
significant APD alternans appeared at a CL of 240 ms (Fig. 3.1B). Varying RyR2
inactivation rate constant (kiCa) had the greatest effect on alternans onset CL in the
human cAF-remodeled tissue (Fig. 3.2A). In fact, only reduction of kiCa resulted in
alternans onset at CLs of 300 ms to 500 ms (Fig. 3.2B), matching alternans onset CLs
observed in AF patients [18]. When other ionic model parameters were varied from
their original cAF values, APD alternans either did not appear in the tissue model
at CLs≥ 300 ms (Fig. 3.2A, blue areas), appeared only at CLs≤ 350 ms (Fig. 3.2A,
red areas), or did not appear before loss of capture or conduction block occurred in
the tissue (Fig. 3.2A, white spaces). These results suggest that altered RyR2 kinetics
is the critical cellular component underlying the occurrence of APD alternans in AF
patients at pacing rates near rest, and that kiCa plays a key role in this process.
We also tested whether differences between left and right atrial electrophysiology
affect alternans susceptibility using a RA version of the cAF model [40] in tissue simu-
lations. Results for RA tissue were very similar to those for LA tissue, demonstrating
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Table 3.1: Ionic model parameters used in sensitivity analysis
Parameter Description
ḡNa maximum fast Na
+ current conductance
ḡNaL maximum late Na
+ current conductance
ḡCaL maximum L-type Ca
2+ current conductance
τf L-type Ca
2+ current voltage-dependent inactivation time constant
τfCa L-type Ca
2+ current Ca2+-dependent inactivation time constant
ḡK1 maximum inward rectifier K
+ current conductance
ḡKr maximum delayed rectifier K
+ current conductance
ḡKs maximum slowly activating delayed rectifier K
+ current conductance
ḡKur maximum ultra-rapid delayed rectifier K
+ current conductance
ḡto maximum transient outward K
+ current conductance
ĪNCX maximal Na
+/Ca2+ exchanger (NCX) current
ks SR Ca
2+ release rate constant
kim transition rate constant for RyR2
kom transition rate constant for RyR2
kiCa RyR2 inactivation rate constant
koCa RyR2 activation rate constant
kleak SR Ca
2+ leak rate constant
VmaxSRCaP Vmax of SERCA pump
ec50SR EC50 for luminal Ca
2+ dependence of RyR2
Kmf Km for SERCA pump in forward mode
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Figure 3.2: Left atrial tissue parameter sensitivity analysis
Parameter sensitivity analysis was performed in LA cAF tissue in order to identify
ionic model parameters that influence alternans. A. Parameters were scaled one
at a time between 25% (short ticks) and 200% (long ticks) of their cAF model
values (25% increments). Only decreasing kiCa produced alternans at the longest
CLs. B. kiCa was scaled between 25% and 100% in 5% increments, producing a
range of APD alternans onset CLs between 300 ms to 750 ms. For (A) and (B),
ANM is indicated by the colorbar (>0.05 considered significant). Simulations
with loss of capture or conduction block are colored in white.
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Figure 3.3: APD alternans onset comparison between model and patients
Comparison of alternans onset in persistent AF patients and in the cAFalt tissue
model. Mean± SD alternans onset data during atrial pacing in persistent AF
patients (white bars) were taken from Table 2 in Ref. [18]. When the cAFalt
tissue model was paced similarly, alternans onset CL, mean APD at onset, and
APD alternans magnitude at onset were within one SD of clinical data (gray
bars).
that modulation of kiCa could reproduce alternans observed at pacing rates near rest
in both the LA and RA of AF patients [18] (Fig. 3.11).
When kiCa was decreased by 50% in the cAF model (we refer to this as the cAFalt
ionic model), APD alternans onset data from the human AF tissue model agreed
well with data from persistent AF patients. Significant APD alternans began at
400-ms CL (Fig. 3.1B, dotted red line), mean APD at onset was 229 ms, and APD
alternans magnitude at onset was 27 ms (Fig. 3.1C, dotted red line). These metrics
were each within one standard deviation (SD) of clinical observations [18] (Fig. 3.3).
The cAFalt model also displayed noticeable alternans in [Ca
2+]i at the onset CL
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(Fig. 3.1D). For both the cAF and cAFalt models, mean APDs were shorter than in
the control model (Fig. 3.1B–C), and diastolic and systolic [Ca2+]i were lower than in
control (Fig. 3.1D). At 400-ms CL in the cAFalt model, on the odd (long) versus the
even (short) beat (Fig. 3.4, blue vs. red), there was higher SR Ca2+ load before release
(0.288 vs. 0.273 mM), higher peak RyR2 open probability (RyRo) (9.0e−4 vs. 4.7e−4),
a larger intracellular CaT amplitude (∆[Ca2+]i=0.13 vs. 0.067 µM), similar ICaL
(integrated over one beat: 144 vs. 140 mC/F), and increased NCX current (INCX)
(integrated over one beat: 98.4 vs. 74.5 mC/F). The positive coupling between Vm and
Ca2+, with INCX as the primary electrogenic current, is consistent with experimental
findings [49]. Since the magnitude and onset of APD alternans in the cAFalt model
provided the best agreement with clinical APD alternans data (Fig. 3.3), we chose to
use this model for subsequent investigations into the underlying causes of alternans
occurrence.
3.3.2 SR Ca2+ release underlies alternans onset
Since APD alternans throughout the homogeneous cAFalt tissue preparation was
concordant and of similar magnitude (Fig. 3.12), electrotonic effects and CV restitu-
tion were excluded as factors influencing alternans. Indeed, APD and CaT alternans
in the cAFalt tissue model were very similar to alternans in the isolated single-cell
cAFalt model (Fig. 3.5, left column vs. Fig. 3.4, top row). We therefore concluded that
cellular mechanisms gave rise to alternans in the cAFalt tissue model and decided to
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Figure 3.4: Alternans in cAFalt tissue at the onset CL
The odd (blue) and even (red) beats at the alternans onset CL (400 ms) are
shown superimposed. Large Ca2+ release occurred during the long beat (blue
traces). Top (left to right): transmembrane potential (Vm), intracellular Ca
2+
concentration ([Ca2+]i), and SR Ca
2+ concentration ([Ca2+]SR). Bottom (left to
right): RyR2 open probability (RyRo), L-type Ca
2+ current (ICaL), NCX current
(INCX).
utilize single-cell simulations in order to investigate these mechanisms. We first used
the ionic model variable clamping protocol described in detail in Section 3.2.4.1. The
percent change in APD and CaT alternans magnitudes, when each ionic model vari-
able was clamped to its trace from either the even (short) or odd (long) steady-state
beat at the alternans onset CL (400 ms), are summarized in Figure 3.6. Variables
which resulted in >99% reduction in APD and CaT alternans magnitudes for both
even and odd beat clamps were considered essential for alternans.
Clamping Vm resulted in −61.8% and +6.6% change in CaT alternans magnitude
for even and odd beat clamps, respectively, demonstrating that alternans was not
voltage-driven (column 2 of Figs. 3.5 and 3.13). Clamping [Ca2+]i enhanced APD
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alternans (+55.2% and +75.8% for even and odd beat clamps, respectively, column 3
of Figs. 3.5 and 3.13). However, when SR Ca2+ ([Ca2+]SR) was clamped to either
the even or odd beat waveforms, alternans in both APD and CaT was eliminated
(<−99%), demonstrating that alternans was driven by SR Ca2+ instability (column 4
of Figs. 3.5 and 3.13). In addition, four other variables could be clamped to the even
or odd beat waveforms to eliminate APD and CaT alternans: RyR2 inactivated prob-
ability (RyRi), RyRo, junctional Ca
2+ concentration ([Ca2+]j), and SR Ca
2+ release
flux (JSRCarel) (Figs. 3.6, 3.14, and 3.15). All five of these variables were therefore
critical for enabling alternans to occur at the onset CL. Furthermore, these variables
directly impact SR Ca2+ release, implicating SR Ca2+ release as the underlying source
of alternans in the cAFalt model.
There were two ionic model components which greatly reduced but did not elim-
inate alternans when clamped: sub-sarcolemmal Ca2+ concentration ([Ca2+]sl) and
sub-sarcolemmal NCX current (INCXsl). Clamping [Ca
2+]sl to the even beat elimi-
nated all alternans; clamping to the odd beat greatly reduced APD and CaT alternans
(−95.8% and −96.2%, respectively), although large alternation in SR load persisted
(Fig. 3.6 and columns 1–2 of Fig. 3.16). Similarly, clamping INCXsl to the even beat
waveform resulted in elimination of APD but not CaT alternans (+72.9%), while
clamping to the odd beat waveform resulted in elimination of all alternans (Fig. 3.6
and columns 3–4 of Fig. 3.16). Hence, SR Ca2+-driven instabilities produced alternans
in Ca2+ cycling which positively coupled to voltage through INCXsl and [Ca
2+]sl.
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Figure 3.5: Clamping Vm and Ca
2+ to odd beat waveforms
Vm or Ca
2+ was clamped to odd beat waveforms in the cAFalt single-cell model.
Traces of transmembrane potential (Vm, row 1), intracellular Ca
2+ concentration
([Ca2+]i, row 2), and SR Ca
2+ concentration ([Ca2+]SR, row 3) from two consecu-
tive beats are superimposed to show alternans between even (red) and odd (blue)
beats. Column 1: the unclamped cAFalt cell paced to steady state at 400 ms CL
displayed alternans in Vm and Ca
2+. The red traces depicted in column 1 were
used to clamp Vm (column 2), [Ca
2+]i (column 3), or [Ca
2+]SR (column 4). Alter-
nans persisted when Vm or [Ca
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Figure 3.6: Summary of ionic model variable clamping
Bar graphs show the percent changes in APD and CaT alternans magnitudes
in the cAFalt cell when ionic model variables were clamped to even or odd beat
waveforms. Alternans were eliminated (>99% decrease in APD and CaT alter-
nans magnitudes for both even and odd beat waveforms) only when SR release
variables were clamped (JSRCarel , RyRo, RyRi, [Ca
2+]SR, and [Ca
2+]j). Gating
variable f (asterisk) displayed higher order instability when clamping to the even
beat waveform, so the increase in alternans magnitude was considered infinitely
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Figure 3.6: Summary of ionic model variable clamping
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3.3.3 Steepening of the SR Ca2+ release slope re-
sults in alternans
Increased steepness of the SR release-load relationship is a well-known mechanism
for CaT alternans [44, 50]. The importance of SR Ca2+ release variables for APD
and CaT alternans, as demonstrated by the results in Figures 3.5, 3.6, 3.13, 3.14
and 3.15, led us to hypothesize that such a mechanism might give rise to Ca2+-driven
alternans in the cAFalt model at pacing rates near rest. To test this, we compared
the cAF and cAFalt ionic models under AP voltage clamp conditions so that changes
in CaT alternans would be due solely to changes in Ca2+ homeostasis rather than
bidirectional coupling between Vm and Ca
2+. After clamping each ionic model at a
CL of 400 ms until steady state was reached, we perturbed [Ca2+]SR and tracked SR
load and SR Ca2+ release on the subsequent clamped beats (see Section 3.2.4.2 for
details). The SR release-load relationships for the cAF (black) and cAFalt (red) ionic
models are depicted in Fig. 3.7 (left column, row 1). The slope of the release-load
relationship in the cAFalt model (3.1) was much greater than the slope in the cAF
model (1.7), confirming our hypothesis that differences between the cAF and cAFalt
ionic models led to a steepening of the SR Ca2+ release slope.
To better explain the differences between the cAF and cAFalt ionic models that
gave rise to different SR Ca2+ release slopes, we first compared [Ca2+]SR, RyRo,
[Ca2+]j, and cumulative Ca
2+ release for the two models at steady state (Fig. 3.7, left
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column, rows 2–5, solid lines). In the cAFalt model, SR [Ca
2+] at steady state was
19.7% lower than in the cAF model as a result of increased RyR2 opening (Fig. 3.7,
left column, rows 2 and 3, red vs. black solid lines). Although this led to a 15.2%
decrease in peak [Ca2+]j in the cAFalt model, the duration of the release event was
prolonged (Fig. 3.7, left column, row 4, red vs. black solid lines). Consequently, though
cumulative Ca2+ release in the cAFalt model initially lagged behind, at t ≈ 90 ms it
actually surpassed the cumulative release in the cAF model, ultimately resulting in a
3.4% increase in total release by the end of the beat (Fig. 3.7, left column, row 5, red
vs. black solid lines).
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Figure 3.7: Effect of RyR2 inactivation on SR Ca2+ release slope
Left column: simulations using the original cAF (black) and cAFalt (red) models.
Right column: simulations in which the original RyR2 model, which included
Ca2+-dependent inactivation, was replaced with the Sato-Bers RyR2 model, which
utilizes CSQN regulation instead (see Table 3.2). In the Sato-Bers model, the SR
is divided into junctional (JSR) and network (NSR) compartments. Top row:
Total Ca2+ released from the SR is plotted against SR Ca2+ load under AP
voltage clamp conditions (CL=400 ms). The line of best fit is also plotted,
with its slope value (the SR Ca2+ release slope) shown next to the data points.
(In column 2, the first beat was excluded.) Modulating RyR2 inactivation by
reducing kiCa (left column) or k34 (right column) by 50% increased the SR Ca
2+
release slope in both models. Rows 2–6: Traces from a similar set of AP voltage
clamp simulations. After reaching steady state (solid lines), SR or NSR load was
perturbed at the beginning of the beat by a large amount (+20 µM, dashed lines)
to illustrate the changes affecting SR Ca2+ release slope. Row 2: SR or JSR
Ca2+ ([Ca2+]SR/JSR). Row 3: RyR2 open probability. Row 4: junctional Ca
2+
concentration. Row 5: total Ca2+ released. Row 6: the difference in total Ca2+
release between perturbed and unperturbed (steady state) simulations. Insets in
column 2, rows 3–4 show traces from t = 0–50 ms.
(next page)
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Figure 3.7: Effect of RyR2 inactivation on SR Ca2+ release slope
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To illustrate how these differences between the cAF and cAFalt ionic models im-
pacted SR Ca2+ release slope, we applied a large perturbation to [Ca2+]SR (+20 µM)
at the beginning of a clamped beat and compared the unperturbed (steady state,
solid line) and perturbed (dotted line) traces for each model (Fig. 3.7, left column,
rows 2–6). Higher SR load at the beginning of the beat led to increased SR release flux
due to luminal Ca2+ regulation of the RyR2 (causing more opening), as well as to the
increased concentration gradient between the SR and junctional compartments. In
both the cAF and cAFalt models, these changes led to increased peak [Ca
2+]j (+54.4%
and +100%, respectively) and RyR2 opening (+64.6% and +129%, respectively) as
a result of more Ca2+-induced Ca2+ release (Fig. 3.7, left column, rows 2–4). The
positive feedback relationship between [Ca2+]j and RyR2 opening was strong enough
such that when SR load was increased (Fig. 3.7, left column, row 2, dotted vs. solid
lines), this actually resulted in a lower minimum [Ca2+]SR during release (−3.6% and
−13.3% for cAF and cAFalt models, respectively). However, the amount of positive
feedback differed between the cAF and cAFalt ionic models. Positive feedback ampli-
fies changes in release inputs, such as SR load; therefore, in the cAF model, where
[Ca2+]j is higher and positive feedback is stronger, the increase in [Ca
2+]SR produced
a slightly greater change in release (compared to the unperturbed, steady state sim-
ulation) during the rising phase of [Ca2+]j (t < 48 ms) than in the cAFalt model
(Fig. 3.7, left column, row 6, black vs. red).
By contrast, termination of release occurs through a negative feedback process,
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with RyRs inactivating upon the binding of junctional Ca2+. Negative feedback
attenuates changes in release so that robust, fast termination of release is achieved
even when a disturbance (such as a transient increase in SR load) occurs. In the
cAFalt model, negative feedback is decreased both directly, via reduction of kiCa, and
indirectly, via reduction in [Ca2+]j that occurs as a result of decreased SR load. This
causes prolongation of the Ca2+ release event and a larger peak [Ca2+]j (Fig. 3.7, left
column, row 4, red vs. black dotted lines). Consequently, when SR load was increased
by the same amount in the cAF and cAFalt models, although the cAFalt model had
a lesser initial change in release because of weaker positive feedback, it also had a
greater final change in release, i.e. a steeper SR release-load relationship, because of
weaker negative feedback (Fig. 3.7, left column, row 6, red vs. black).
The results in column 1 of Fig. 3.7 demonstrate how the steeper SR Ca2+ release
slope in the cAFalt ionic model (as compared to the cAF ionic model) depends upon
RyR2 inactivation by junctional Ca2+. However, recent work suggests that termina-
tion of release does not rely on direct Ca2+-dependent inactivation of the RyR2 but
rather on local SR Ca2+ depletion [51–54]. In order to test whether steepening of
the SR Ca2+ release slope could occur in the cAF model by an alternative release
termination mechanism, we implemented a version of the cAF model in which the
RyR2 Markov model was replaced with that of Sato and Bers and the SR was di-
vided into junctional (JSR) and network (NSR) compartments [55] (see Table 3.2
and Section 3.5.1.3). Termination of release in this alternative RyR2 model relies on
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calsequestrin (CSQN) binding to the RyR2, which occurs as luminal [Ca2+] decreases
causing changes in RyR2 opening and closing rates.
The effects of decreased RyR2 termination in the Sato-Bers RyR2 model are
shown in the right column of Fig. 3.7. When the CSQN-bound RyR2 closing rate k34
(analogous to the inactivation rate kiCa in the original model) is decreased from 100%
to 50% (cAFalt), steady-state Ca
2+ concentrations change modestly as compared to
the original RyR2 formulation (Fig. 3.7, black vs. red solid lines), but nevertheless
display similar trends: SR [Ca2+] decreases by 1.5% (vs. 19.7%, row 2), peak [Ca2+]j
is reduced by 10.5% (vs. 15.2%, row 4) and delayed, and total release increases by 3.6%
(vs. 3.4%, row 5). When [Ca2+]NSR is perturbed in the Sato-Bers models by +20 µM,
Ca2+ release increases more in the cAFalt model than in the cAF model (Fig. 3.7, right
column, row 6, red vs. black dotted lines). Consequently, the SR Ca2+ release slope is
steeper in the cAFalt model (3.7 vs. 1.9, Fig. 3.7, right column, row 1). Thus, although
changes in SR Ca2+ release slope in the original cAF model are caused by altered
junctional Ca2+-dependent inactivation, altered SR Ca2+-dependent mechanisms of
release termination can produce such changes in SR Ca2+ release slope as well.
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30 - RyR2 opening rate
Ku (ms
-1) - 15 CSQN-unbound RyR2 opening rate
Kb (ms
-1) - 0.015 CSQN-bound RyR2 opening rate
τb (ms) - 0.164 CSQN binding time constant
τu (ms) - 312 CSQN unbinding time constant
τtr (ms) - 5 JSR refilling time constant
VSR / Vcell 0.035 - SR fractional volume
VJSR / Vcell - 0.0035 JSR fractional volume
VNSR / Vcell - 0.0315 NSR fractional volume
VmaxSRCaP
(mMms-1)
5.31e−3 5.04e−2 Vmax of SERCA pump
ks (ms
-1) 25 134 SR Ca2+ release rate constant
Bmaxcsqn
(mM)
2.6 0.4 CSQN concentration
KC (mM) 0.65 0.6 Ca
2+/CSQN dissociation constant
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3.3.4 Iterated map analysis
Although SR Ca2+ release slope is an important component of Ca2+ homeostasis,
other aspects of Ca2+ cycling, such as SR Ca2+ uptake, could also have a significant
impact. In order to understand how both SR release and uptake contribute to CaT
alternans onset at slow pacing rates in human cAF cells, we used an iterated map
analysis for investigating Ca2+ cycling stability under AP voltage clamp conditions.
Three factors affecting Ca2+ cycling stability were included in the analysis: SR release,
SR uptake, and cellular Ca2+ flux across the sarcolemma. The latter factor was
included because Ca2+ content in the human atrial cell model varied significantly
enough to affect alternans threshold predictions.
For each version of the human atrial cell model (cAF and control), we calculated
the SR Ca2+ release slope (m), the SR Ca2+ uptake factor (u), and the cellular Ca2+
efflux factor (κ) [7, 47] for a range of kiCa values and pacing rates and compared the
value of m to the threshold for alternans. For a typical range of parameter values
(u + κ < 1, see Section 3.5.1.4), the threshold value of m required for alternans is





Theoretical analysis predicts that the system is stable when m < mthresh. Equa-
tion 3.2 is graphed for a range of κ values in Figure 3.8A–C (dotted lines). Each
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curve represents the boundary between stable (no alternans) and unstable (alter-
nans) Ca2+ cycling in the u–m plane for a particular value of κ. As κ increases
(Fig. 3.8A–C, dark blue to dark red), the threshold curve steepens, indicating that
increased Ca2+ extrusion from the cell has a protective effect, helping to restore Ca2+
content back to steady state following a perturbation. Thus, a higher value of m is
required to reach alternans threshold for higher values of κ. Note that in this theo-
retical approach, increased Ca2+ efflux (κ) has the opposite effect as in Qu et al. [47],
suppressing rather than promoting Ca2+ alternans.
The effects of changing CL and changing kiCa are explored for the cAF model
in Fig. 3.8A. At the default kiCa value (100%), as CL is decreased from 700 ms to
200 ms (−10-ms increments), u decreases, m increases, and the system approaches the
alternans threshold given by Equation 3.2. The change in κ values is non-monotonic,
initially decreasing (orange to green) and then increasing (green to orange) as CL is
decreased. However, the change in κ has a minimal effect at small u values, since
the threshold curves for different κ values converge at u = 0. At CL< 220 ms, the
cell begins to display alternans in Ca2+ cycling, coinciding with the iterated map
parameter values residing very close to the theoretically predicted boundary given by
Equation 3.2 (Fig. 3.8A, orange x’s). When kiCa is set at 50% of the default cAF
value (cAFalt model), a similar trend is observed. However, the 50% kiCa cAF model
reaches threshold at a lower pacing rate (CL=390 ms for the 50% kiCa cAF model
vs. 210 ms for the 100% kiCa cAF model, Fig. 3.8A, x’s). This is primarily due to
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m increasing as kiCa is decreased, illustrated by the trajectory of the system in the
u–m plane as CL is held constant at 390 ms but kiCa is decreased from 100% to 50%
(Fig. 3.8A).
We next performed the same iterated map analysis for the control atrial cell model
with varying CL and kiCa values (Fig. 3.8B). When kiCa is at 100%, u decreases as
CL is decreased. However, unlike in the cAF model, in the control case the value
of m undergoes a net decrease as CL shortens from 700 ms to 200 ms. Ultimately,
since both m and u decrease as CL is shortened, the control atrial cell (with kiCa at
100%) fails to reach threshold and remains in the stable, no alternans region. This
suggests that alternans in control patients, which occur at CLs<250 ms [18], are
driven by voltage rather than Ca2+. As in the cAF model, the alternans threshold
CL in the control model can be adjusted by modulating the value of kiCa (Fig. 3.8B,
CL=390 ms). However, in the control model, kiCa must be decreased much more
than in the cAF model in order to reach mthresh at a CL of 390 ms (kiCa reduced
to 16% vs. 50%). The need for dramatic and possibly unrealistic reductions in kiCa to
produce alternans at slow rates in control is consistent with the absence of alternans
observed in control patients at CLs≥ 250 ms [18].
To explain the difference in Ca2+ cycling properties of the cAF and control mod-
els, we examined the effects of cAF cellular remodeling on iterated map parame-
ters. Stochastic ionic model parameter variation and regression analysis [56] (see
Section 3.5.1.5) predicted that of the ten model parameters altered in the control
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model to construct the cAF model, seven would have significant effects on alternans
threshold CL (these are ḡCaL, koCa, ḡKur, ĪNCX , ḡto, ḡK1, and ḡNa, see Fig. 3.17). Of
these seven parameters, three are involved in Ca2+ handling: maximum L-type Ca2+
current conductance (ḡCaL), RyR2 activation rate constant (koCa), and maximal NCX
current (IbarNCX). The effects of changing these three parameters from control to
cAF values is depicted sequentially in Fig. 3.8C: starting with the default values for
the control cell at a CL of 390 ms, first ḡCaL is decreased and then ĪNCX and koCa are
increased to cAF values, resulting in an overall decrease in u and m. Finally, when
kiCa is decreased to the cAFalt value (50%), the large increase in m causes the system
to reach mthresh and alternate (Fig. 3.8C, red X). This illustrates why the control cell
is less susceptible to CaT alternans than the cAF cell: at a given kiCa value and
pacing rate, SR uptake efficiency (u) is higher in the control model, thus requiring a
large increase in the pacing rate (which decreases u) and/or a large decrease in kiCa
(which increases m) in order to reach mthresh. Of the three cAF parameters which
decrease u, however, ḡCaL is the most important for alternans onset, since remodeling
of ĪNCX and koCa decreases m, while remodeling of ḡCaL increases m. When ḡCaL is
remodeled and ĪNCX and koCa remain at control values, only a 28% decrease in kiCa
is required to reach mthresh (Fig. 3.8C).
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Figure 3.8: Iterated map analysis of Ca2+ cycling
For each panel, SR Ca2+ release slope (m) is plotted against SR Ca2+ uptake
factor (u), with cellular Ca2+ efflux factor (κ) values indicated in the colorbar.
The boundaries between stable (no alternans) and unstable (alternans) regions in
the u–m plane are denoted by dashed lines for different values of κ (see Eq. 3.2).
Circles and x’s indicate the absence and presence of alternans, respectively. A. Re-
sults for the cAF model. CL is varied, from 700 ms to 200 ms for the 100% kiCa
model and from 700 ms to 300 ms for the 50% kiCa model (i.e., the cAFalt model),
in −10-ms increments. At a CL of 390 ms, kiCa is scaled from 100% to 50% in
−2% increments. B. Same as in panel (A), except that the control cell model
is used, and kiCa is scaled from 100% to 16%. C. Starting with the control cell
parameter values, maximum L-type Ca2+ current conductance (ḡCaL), maximal
NCX current (IbarNCX), and RyR2 activation rate constant (koCa) are sequen-
tially scaled to cAF values, resulting in net decreases in m and u. Finally, kiCa
is scaled to 50% (as in the cAFalt model), and increases sufficiently to reach the
alternans boundary (red X). If only ḡCaL is decreased to the cAF value, then
alternans threshold is achieved at a higher kiCa value (72%, green X).
(next page)
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Figure 3.8: Iterated map analysis of Ca2+ cycling
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3.4 Discussion
3.4.1 Findings and significance
The first goal of this study was to identify the electrophysiological changes in
human atrial cells that are responsible for the occurrence of APD alternans at heart
rates near rest, as observed in AF patients. Using parameter sensitivity analysis,
we found that of the 20 electrophysiological model variables tested, only changes in
the RyR2 inactivation rate constant (kiCa) could produce APD alternans at relatively
slow pacing rates in a tissue model of persistent/chronic AF. In particular, decreasing
kiCa by 50% (the cAFalt model) produced a good match to clinical data. We next
aimed to provide mechanistic insight into why disruption of RyR2 kinetics, together
with other electrophysiological changes occurring in AF, leads to alternans onset at
pacing rates near rest. We established that alternans in the cAFalt model at the onset
CL were Ca2+-driven rather than voltage-driven, and that they depended upon SR
Ca2+ release. Furthermore, CaT alternans occurred in the cAFalt model at relatively
long CLs because of steep SR Ca2+ release slope and decreased SR Ca2+ uptake
efficiency. Lastly, we demonstrated that the ability to generate alternans at slower
pacing rates by modulating kiCa depended upon the negative feedback properties of
SR Ca2+ release.
This study is the first to identify a possible mechanism for alternans occurring
at slow heart rates in AF patients. Our novel findings show that alternans at slow
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rates is Ca2+-driven, brought about by AF-associated remodeling of the Ca2+ han-
dling system in atrial cells. Clinical and experimental research has shown that atrial
alternans is associated with disease progression in AF patients [18] and with increased
AF susceptibility after myocardial infarction [57,58] and atrial tachycardia [59,60] in
animal models. Additionally, CaT alternans have been studied in animal atrial my-
ocytes [37,38,61] and in the intact atria of AF-prone mice [62]. However, the precise
cellular mechanism underlying alternans at heart rates near rest in the remodeled hu-
man atria has not been previously identified, and a direct relationship between human
AF and CaT alternans in the atria has not been established until now. Elucidating
the mechanism driving alternans at slow rates is particularly important because APD
oscillations appear to be closely linked to AF initiation [18]. If APD alternans play a
direct role in AF initiation, the onset of alternans at slower pacing rates would indi-
cate an increased susceptibility to arrhythmia in AF patients, consistent with clinical
observations [18]. Identification of this mechanism would thus provide a significant
scientific and clinical benefit, improving our understanding of arrhythmogenesis and
aiding in the development of new targeted therapies for AF.
In this study, we demonstrate how different aspects of AF remodeling contribute to
Ca2+-driven alternans onset at slower heart rates using a theoretical analysis of Ca2+
cycling. This analysis allowed us to quantitatively assess CaT alternans threshold un-
der AP voltage clamp conditions in a detailed electrophysiological model, providing
valuable insights into the effects of AF electrophysiological remodeling on Ca2+ han-
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dling and alternans. Furthermore, we identify a critical aspect of SR Ca2+ release—
inactivation of the RyR2—which is necessary for CaT alternans to occur at slow
heart rates. These findings extend mechanistic insight about proarrhythmic ventricu-
lar Ca2+ remodeling [35,63,64] to the atria and may inform new therapeutic strategies
to target the RyR2 and suppress Ca2+-driven alternans in the atria for the purposes
of preventing or treating AF [62,65].
3.4.2 RyR2 dysregulation in AF
The RyR2 has been the focus of several studies concerning trigger-mediated AF.
In particular, disruption of RyR2 regulation has been shown to promote AF through
increased RyR2 open probability, diastolic SR Ca2+ leak, and delayed afterdepolar-
izations [33, 65, 66]. Here we identify an additional pathological consequence of the
disruption of RyR2 regulation in AF: Ca2+-driven alternans. Similar to what has
been demonstrated with regards to Ca2+ sparks and triggered activity [65], we found
that CaT alternans is coupled to voltage primarily through upregulated INCX , thus
driving the generation of APD alternans. RyR2’s central role in both alternans and
triggers has important clinical implications, given the proarrhythmic consequences
of interaction between ectopic activity and the arrhythmogenic substrate created by
voltage alternans [67]. New drug treatments to restore the normal function of the
RyR2 and NCX, and thereby prevent arrhythmogenic triggers and alternans, have the
potential to provide more effective alternatives to current AF drug therapies which
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target voltage-gated ion channels and often have proarrhythmic side effects [65].
The signaling pathways involved in RyR2 dysfunction in AF have been the focus
of much active research over the past several years [65,66]. Possible molecular mech-
anisms which could account for reduced RyR2 inactivation include RyR2 hyperphos-
phorylation by CAMKII and PKA and dissociation of the RyR2 subunit FKBP12.6,
which have been shown to increase RyR2 open probability and promote arrhyth-
mia [68], although the exact role of these mechanisms in RyR2 dysregulation are still
debated [69]. Calmodulin has also been shown to interact directly with the RyR2 to
decrease its open probability [70]. Metabolic factors may play a role, since modula-
tion of the RyR2 as a result of glycolytic inhibition has been linked to atrial alternans
in non-AF animal models [36, 37, 61]. Such metabolic impairment is thought to con-
tribute to profibrillatory remodeling in the atria [71–73]. The cAFalt model, with its
reduction in kiCa, can be considered a phenomenological representation of the various
signaling pathway disruptions leading to alternans, which were not represented in the
original cAF model. As more information becomes available, incorporation of these
signaling mechanisms into computational models may provide additional insights into
how reduction in RyR2 inactivation leads to Ca2+-driven alternans at slow heart rates
in AF patients.
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3.4.3 The role of RyR2 refractoriness in CaT
alternans
There is debate over whether CaT alternans depend primarily on SR Ca2+ load
alternation or on RyR2 refractoriness [50, 67, 74]. Recent experiments [8, 38] and
simulation studies [45,75–77] have shown that RyR2 refractoriness can drive CaT al-
ternans under conditions where near-identical SR loads produce different amounts of
SR release. In some simulation studies, this phenomenon was restricted to limited pa-
rameter values, clamping conditions, and cycle lengths [75,76], while in a more recent
modeling study focusing on atrial cells, SR load-independent alternans occurred over
a broad range of pacing rates when the number of T-tubules was reduced [77]. Of note
is the fact that many of these studies [75–77] utilized the same RyR2 gating scheme
as this current study, yet they identified various mechanisms for CaT alternans. This
demonstrates that the relative importance of the various mechanisms, whether SR
load-driven, RyR2 refractoriness-driven, or otherwise, is highly context-dependent.
Although exploring the issue of SR load versus RyR2 refractoriness was beyond
the goals of the current study, our results suggest that in human cAF, both SR load
alternation and RyR2 refractoriness are involved in alternans genesis at slower pac-
ing rates. In our cAFalt model, alternation in all SR Ca
2+ release variables, including
[Ca2+]SR, RyR2 open probability, and RyR2 inactivated probability, was necessary
for alternans at the onset CL of 400 ms (Fig. 3.6). In addition, SR Ca2+ uptake flux
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(JSERCA) enhanced alternans when clamped (Fig. 3.6) and therefore suppressed alter-
nans under normal pacing conditions, suggesting that SR load is indeed an important
driver of CaT alternans in cAF and that upregulation of the sarco/endoplasmic retic-
ulum Ca2+-ATPase (SERCA) pump may be an important therapeutic strategy for
diminishing alternans. We also showed that CaT alternans occurred in the cAFalt
model at slow pacing rates because decreased RyR2 inactivation resulted in steep-
ening of the SR release-load relationship. Together, these results indicate that the
interplay between SR load and RyR2 kinetics is responsible for alternans onset in
human AF.
3.4.4 Other potential mechanisms for alternans
susceptibility
The mechanisms for human atrial alternans susceptibility are likely to encompass
a range of complex interactions at multiple scales of biology, which extend beyond the
cellular-level mechanisms found here. In this study we examined the behavior of an
atrial cell with well-developed T-tubules [40]. Research has shown that rat atrial cells
have variable levels of T-tubule organization [78]. Such variation, if present in human
atrial cells, would result in subcellular Ca2+ gradients which could make cells more
susceptible to alternans [37,79,80]. Models of atrial myocytes incorporating detailed
spatial descriptions [81] and local control of Ca2+ [13] will aid in future investigations
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of the subcellular mechanisms of cAF-related alternans.
In addition, the complex structure of the atria, including its normal conduction
pathways [41] and fibrotic remodeling in AF [82, 83], may promote heterogeneity
and discordant alternans, which significantly affect alternans dynamics and reentry
initiation [17, 84]. Consideration of these factors in the future will further enrich the
mechanistic insight gained from this current study and will advance our understanding
of the role that alternans play in AF arrhythmogenesis.
3.4.5 Limitations
In many cell models, the effective refractory period (ERP) is not consistent with
ERP at the tissue level [85]. Electrotonic effects in tissue and the whole heart can
shorten or lengthen APD depending on which structures and cell types are coupled
to each other. Furthermore, alternans in single cell models may not be predictive
of alternans in tissue, where conduction alternans can occur. This was the case for
the control atrial tissue model, in which loss of capture occurred at a CL of 260 ms
before reaching the very fast pacing rates at which APD alternans were observed in
human control patients (CL=218±30 ms) [18]. However, alternans onset at clinically
observed rates occurred in the single-cell control model (200-ms CL, Fig. 3.18, black
curve) and when kiCa was reduced by 5% (230-ms CL, Fig. 3.18, red curve). This
suggests that the ionic model may not be well-constrained for tissue simulations at
very fast rates. However, this issue did not affect the study of alternans onset at
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slower pacing rates, as was observed in AF patients.
Our ionic model variable clamping protocol, which involved separately clamping
the even or odd beat waveforms, was used to test for model variables which could
robustly suppress alternans when clamped to either of two very different waveforms.
An alternative approach would be to clamp model variables to the single unstable,
non-alternating waveform obtained using a control algorithm [86]. This approach
would allow more precise assessment of fixed point stability, since clamping is done at
the point of instability rather than during the bistable (alternans) endpoint. However,
for the purposes of quantifying the most important variables influencing instability,
the clamping protocol used in this study was sufficient to identify the central role of
SR Ca2+ release, which was later confirmed through iterated map analysis.
Recent experimental evidence points towards local SR Ca2+ depletion, rather than
Ca2+-dependent RyR2 inactivation, as the main mechanism of SR release termina-
tion [51–54]. Although alternans in the cAFalt model relied on Ca
2+-dependent RyR2
inactivation, other termination mechanisms which rely on SR Ca2+ (used in the Sato-
Bers RyR2 model) may have similar effects on SR Ca2+ release slope and alternans
susceptibility (Fig. 3.7, column 2). However, with the Sato-Bers RyR2 model, alter-
nans and other complex oscillations began at the baseline pacing rate (750-ms CL,
Fig. 3.19) and did not display the same rate dependence observed in patients [18]. In
addition, large oscillations in CaT amplitude did not couple as strongly to voltage
as with the original RyR2, and oscillations were also attenuated in tissue (Fig. 3.19).
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Further work is needed to develop atrial cell models which incorporate current mech-
anistic understanding of SR Ca2+ release and which can also reproduce AF-related
alternans rate dependence in tissue.
3.4.6 Conclusion
AF is associated with progressive changes in alternans onset in the human atria,
with alternans occurring at slower heart rates as AF severity worsens. We found that
the differences in alternans onset between AF and control patients could be accounted
for by changes in the inactivation rate of the RyR2 in a model of human atrial cAF-
remodeled tissue. Single-cell simulations revealed that alternans at these slow heart
rates were driven by abnormal Ca2+ handling and the development of CaT alternans,
and that changes in CaT alternans threshold resulted from steepening of the SR Ca2+
release slope, decreased SR Ca2+ uptake efficiency, and decreased inactivation of the
RyR2. These findings provide important insight into the mechanisms underlying
proarrhythmic APD alternans occurring at slow heart rates in AF patients. Such
insight may aid in the development of targeted therapies and new treatment strategies
for AF in the future.
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3.5 Appendix
3.5.1 Supplemental Methods
3.5.1.1 Modifications to the GPV model
The Grandi-Pandit-Voigt human atrial action potential model (GPV) model failed
to propagate robustly when paced at faster rates (Fig. 3.9, black trace). We substi-
tuted fast Na+ current (INa) kinetics of the original model with the formulation from
the Luo-Rudy dynamic model (LRd) [87] to achieve normal propagation, as done
previously [88] (Fig. 3.9, blue trace). Maximum fast Na+ current conductance (ḡNa)
was set to 14 mS/µF to reproduce maximum upstroke velocity (208 V/s) and action
potential amplitude (105 mV) values reported previously [89, 90]. In addition, we
reduced the number of state variables in the GPV model using a rapid equilibrium
approximation for Ca2+ and Na+ buffers with fast kinetics (Section 3.5.3.1). This
decreased the computation time for tissue simulations by about 6X. The modified
GPV model (GPVm) with LRd INa kinetics and fewer state variables was used for
all simulations in this study unless otherwise indicated.
3.5.1.2 Inter-atrial heterogeneity and cAF remodeling
For the modified GPV model (GPVm) model, we implemented the changes de-
scribed by Grandi et al. for the LA and RA [40]. In normal cells, maximum ultra-
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Figure 3.9: Comparison of GPV and GPVm models
At 400-ms CL, the original GPV model did not propagate robustly in tissue (black
line). When fast Na+ current (INa) kinetics was replaced with the kinetics from
the Luo-Rudy dynamic model (LRd), normal propagation occurred (blue line).
Applying the fast equilibrium approximation to select buffers (Section 3.5.3.1)
had a negligible effect on simulation results (dotted green line).
rapid delayed rectifier K+ current conductance (ḡKur) is increased by 20% in the RA
as compared to the LA. In cAF cells, ḡKur and maximum transient outward K
+ cur-
rent conductance (ḡto) are differentially downregulated from their normal levels, with
ḡKur decreased by 45% and 55% and ḡto decreased by 45% and 80% in the LA and
RA, respectively. Additionally, modifications of the action potential under conditions
of cAF included the following changes that occurred in both LA and RA: a 10%
decrease in ḡNa, addition of a late component to the sodium current (INaL), a 50%
decrease in ḡCaL, a 40% increase in ĪNCX , a 3-fold increase in koCa, a 25% increase
in SR Ca2+ leak, a 2-fold increase in maximum slow delayed rectifier K+ current
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3.5.1.3 Sato-Bers RyR model implementation
Model parameters which were modified for implementation of the Sato-Bers RyR2
model [55] are listed in Table 3.2. The SR was divided into junctional (JSR) and
network (NSR) compartments, the former of which contained the Ca2+ buffer CSQN.
Equations for CSQN buffering in the Sato-Bers model were derived from Restrepo
et al. [45] (Section 3.5.3.2). RyR2 equations were updated as described in Sato and
Bers [55] (Section 3.5.3.3).
3.5.1.4 Iterated map derivation
Figure 3.10: Schematic of Ca2+ cycling used in iterated map analysis
Rn is the total amount of SR Ca
2+ release on beat n, which depends on SR load
(ln) (Eq. 3.3). Un is the total amount of SR Ca
2+ uptake on beat n, which depends
on peak cytoplasmic Ca2+ (cpn) (Eq. 3.4). En is the net Ca
2+ efflux from the cell
on beat n, which depends on peak cytoplasmic Ca2+ (cpn) (Eq. 3.7).
We used an iterated map analysis to derive Ca2+ cycling stability criteria. For
small SR load perturbations near steady state, total SR release (Rn) and uptake (Un)
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on each beat changed linearly from beat to beat [7, 44]:




m is the SR Ca2+ release slope, u is the SR Ca2+ uptake factor, and ∆ln and ∆c
p
n
are the changes in total SR load and peak cytoplasmic Ca2+, respectively, from beats
n − 1 to n. We did not consider Ca2+-induced Ca2+ release (CICR) and SR leak
separately since both were linearly dependent on SR load near steady state and their
effects added linearly. Peak cytoplasmic Ca2+ was defined as:
cpn = bn − ln +Rn (3.5)
where bn is the total Ca
2+ content in the cell at the start of beat n. Equations 3.3–
3.5 were used to construct the first mapping equation describing the change in SR
load [7, 44,47]:
∆ln+1 = ∆ln −m∆ln + u (∆bn −∆ln +m∆ln) (3.6)
Note that we did not assume ∆bn to be zero. We also incorporated a new equation
for net Ca2+ efflux from the cell (En), which depended linearly on peak cytoplasmic
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κ is the sarcolemmal Ca2+ efflux factor. Equations 3.3, 3.4, and 3.7 were used to find
the linear least squares fit values of m, u, and κ based on Rn, Un, En, c
p
n, and ln.
The Ca2+ efflux term (Eq. 3.7) was used to construct the second mapping equation
describing the change in total Ca2+ content [47]:
∆bn+1 = ∆bn − κ (∆bn −∆ln +m∆ln) (3.8)
Though iterated map analysis lacking this second mapping equation has been previ-
ously used [44], the addition of the second equation provided more accurate theoretical
predictions of Ca2+ alternans thresholds in our simulations.






The criteria for stability are that both eigenvalues of the Jacobian have absolute value
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⏐⏐⏐(1−m)(1− u)− κ+ 1±√((1−m)(1− u)− (1− κ))2 + 4uκ(1−m)⏐⏐⏐ < 1
(3.10)
Under physiological conditions where the iterated map parameters are positive and









+ 1 , u+ κ > 1 (3.12)
for Ca2+ cycling to be stable.
3.5.1.5 Regression analysis
We used multivariable regression analysis methods from Sobie et al. to estimate
the contribution of model parameters to the alternans threshold pacing CL [56].
Twenty model parameters (Table 3.1) were scaled (from control LA values) stochas-
tically and independently according to a lognormal distribution with a median of 1
and σ=0.2. A total of 500 sets of parameter scaling values were generated and used
in single-cell simulations.
To determine the alternans threshold CL (output) for a given set of parameter
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scaling values (input), each cell was first paced to steady state at a CL of 400 ms.
Then CL was progressively increased or decreased by 1 ms every 100 beats until APD
alternans ceased (alternans≤ 1%) or began (alternans> 1%), depending on whether
alternans was present at a CL of 400 ms or not. Alternans threshold CL was defined
as the shortest CL at which alternans did not occur. Any cell in which alternans
persisted at CLs up to 750 ms or in which alternans was absent at CLs down to 100 ms
was excluded from the analysis. Input and output matrices were log-transformed,
then mean-centered and normalized by SDs (column-wise), before performing linear
regression [56]. The regression coefficients obtained by this method indicate which
parameters the model is most sensitive to with regards to alternans threshold CL,
under assumptions of linearity. Linear regression was performed using MATLAB’s
LinearModel.fit function. Each parameter coefficient was considered significant if the
p-value of its t-statistic was <0.05. To evaluate the predictive ability of the regression
analysis, we multiplied the regression coefficients by parameter scaling values for the
cAF model (log-transformed, mean-centered, and normalized) to obtain the predicted
contribution of each parameter to changes in alternans CL [91].
3.5.2 Supplemental Figures
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Figure 3.11: Right atrial tissue parameter sensitivity analysis
Parameter sensitivity analysis was performed in tissue with the right atrium ver-
sion of the GPVm model incorporating cAF remodeling, in order to identify ionic
model parameters that influence alternans. Parameters were scaled one at a time
between 25% (short ticks) and 200% (long ticks) of their cAF model values (25%
increments). Results were similar to those obtained with the LA version of the
model (see Fig. 3.2A), with alternans occurring at the longest CLs only when kiCa
was decreased. ANM is indicated by the colorbar (<0.05 considered significant).
Simulations with loss of capture or conduction block are colored in white.
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Figure 3.12: Concordant APD alternans in cAFalt tissue
The tissue preparation was paced from the stimulus electrode (see Fig. 3.1A),
and APD alternans normalized magnitude (ANM) was quantified at each CL for
every node along the tissue. When significant alternans was present in the tissue
(ANM> 0.05), all nodes had concordant alternans of similar magnitude.
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Figure 3.13: Clamping Vm and Ca
2+ to even beat waveforms
Vm or Ca
2+ was clamped to even beat waveforms in the cAFalt single-cell model.
Traces of transmembrane potential (Vm, row 1), intracellular Ca
2+ concentration
([Ca2+]i, row 2), and SR Ca
2+ concentration ([Ca2+]SR, row 3) from two consecu-
tive beats are superimposed to show alternans between even (red) and odd (blue)
beats. Column 1: the unclamped cAFalt cell paced to steady state at 400 ms CL
displayed alternans in Vm and Ca
2+. The blue traces depicted in column 1 were
used to clamp Vm (column 2), [Ca
2+]i (column 3), or [Ca
2+]SR (column 4). Alter-
nans persisted when Vm or [Ca
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Figure 3.14: Clamping SR Ca2+ release parameters to even beat waveforms
SR Ca2+ release parameters were clamped to even beat waveforms in the cAFalt
single-cell model. Traces of transmembrane potential (Vm, row 1), intracellular
Ca2+ concentration ([Ca2+]i, row 2), and SR Ca
2+ concentration ([Ca2+]SR, row 3)
from two consecutive beats are superimposed to show alternans between even
(red) and odd (blue) beats. Traces from the even beat at 400 ms CL pacing
were used to clamp the relevant variable and are shown in row 4. Clamping
RyR2 inactivated probability (RyRi, column 1), RyR2 open probability (RyRo,
column 2), junctional Ca2+ concentration ([Ca2+]j, column 3), or SR Ca
2+ release
flux (JSRCarel , column 4) eliminated alternans in Vm and Ca
2+.
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Figure 3.15: Clamping SR Ca2+ release parameters to odd beat waveforms
SR Ca2+ release parameters were clamped to odd beat waveforms in the cAFalt
single-cell model. Traces of transmembrane potential (Vm, row 1), intracellular
Ca2+ concentration ([Ca2+]i, row 2), and SR Ca
2+ concentration ([Ca2+]SR, row 3)
from two consecutive beats are superimposed to show alternans between odd
(red) and odd (blue) beats. Traces from the odd beat at 400 ms CL pacing
were used to clamp the relevant variable and are shown in row 4. Clamping
RyR2 inactivated probability (RyRi, column 1), RyR2 open probability (RyRo,
column 2), junctional Ca2+ concentration ([Ca2+]j, column 3), or SR Ca
2+ release
flux (JSRCarel , column 4) eliminated alternans in Vm and Ca
2+.
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Figure 3.16: Clamping sub-sarcolemmal parameters
Sub-sarcolemmal parameters were clamped to even or odd beat waveforms in
the cAFalt single-cell model. Traces of transmembrane potential (Vm, row 1),
intracellular Ca2+ concentration ([Ca2+]i, row 2), and SR Ca
2+ concentration
([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans
between odd (red) and odd (blue) beats. Traces from the odd beat at 400 ms
CL pacing were used to clamp the relevant variable and are shown in row 4.
Clamping sub-sarcolemmal Ca2+ concentration ([Ca2+]sl) to the even beat (col-
umn 1) eliminated alternans in Vm and Ca
2+, but clamping [Ca2+]sl to the odd
beat (column 2) produced small alternans in Vm and [Ca
2+]i and large alternans
in [Ca2+]SR. Clamping sub-sarcolemmal NCX current (INCXsl) to the even beat
(column 3) eliminated alternans in Vm but produced large alternans in [Ca
2+]i
and [Ca2+]SR. Clamping INCXsl to the odd beat (column 4) eliminated alternans
in Vm and Ca
2+.
75
CHAPTER 3. DISRUPTED CALCIUM RELEASE
Figure 3.17: Multivariable regression parameter sensitivity analysis
Multivariable regression was used to assess the contribution of ionic model pa-
rameters to alternans threshold CL. A. Bar graph of regression coefficient mag-
nitudes. Twenty ionic model parameters were varied stochastically over 500 sim-
ulations to assess their effects on alternans threshold CL. Of the 500 simulations,
83 were excluded from the analysis because alternans threshold CL was below
100 ms or above 750 ms. Linear regression coefficients for each of the param-
eters are plotted in order of decreasing magnitude, with positive values plotted
in red and negative values plotted in blue. Asterisks indicate p < 0.05 for the
t-statistic. B. Bar graph of the predicted contribution of parameters to alter-
nans threshold CL in the cAF-remodeled cell. Ten of the twenty parameters
used in the regression analysis were altered from control values to represent cAF
remodeling (increases and decreases indicated by upward and downward arrows,
respectively). Parameters whose changes were predicted to increase (decrease) the
alternans CL are plotted in red (blue). Some unaltered parameters had nonzero
predicted contributions to alternans threshold CL due to nonzero sample means
from the regression analysis. The alternans threshold CL predicted by regression
analysis (245 ms) was very close to the actual alternans threshold CL determined
by simulation (244 ms).
(next page)
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Figure 3.17: Multivariable regression parameter sensitivity analysis
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Figure 3.18: APD restitution in control single cell model
With default model parameter values, APD alternans occurred at 200 ms CL
(black). When the RyR2 inactivation rate constant (kiCa) was reduced to 95%,
alternans occurred at slightly longer CLs (red). These results were comparable
to alternans onset data from control patients [18].
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Figure 3.19: APD and CaT oscillations with Sato-Bers RyR2 model
Control (black), cAF (red), and cAFalt (dotted red line) versions of the model
using the Sato-Bers RyR2 [55] were implemented in single cell (A and B) and
in tissue (C and D). In the cAFalt model, the CSQN-bound RyR2 closing rate
(k34) was decreased by 50%. APD (A and C) and CaT (B and D) restitution
data are plotted showing the mean± SD range (control, gray shading, not visible;
cAF, pink shading; cAFalt, red hatching). Oscillations in APD and CaT included
but were not limited to alternans. Oscillations exhibited the reverse of the rate
dependence observed in models using the original RyR2 formulation, with larger
oscillations at longer CLs. APD oscillations in these models were diminished as
compared to the original models (see Fig. 3.1), and both APD and CaT oscillations
were attenuated in tissue.
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3.5.3 Supplemental Equations
3.5.3.1 Rapid equilibrium approximation
Cai compartment (CaM and SRB):
JCaBcytosol =
˙TnCl + ˙TnChC +
˙MyoC (3.13)
βCai =
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2 + w (3.31)
k21 = 0.5 ms
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Decreased wavelength in the atria is a well-established mechanism of atrial fibril-
lation (AF) that supports conditions for reentry and thereby promotes AF initiation
and maintenance [34]. Recently, efforts to understand the mechanisms of AF have
focused increasingly on other aspects of AF remodeling, such as Ca2+ handling ab-
normalities [33] and alternans [17], the beat-to-beat alternation in cardiac electrical
signals. Clinical evidence suggests that atrial alternans may play an important role
in human AF [17]; however, it remains difficult to determine experimentally whether
alternans as a secondary consequence of atrial remodeling in patients has a significant
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effect on arrhythmogenesis. Understanding the role of atrial alternans in arrhythmo-
genesis will be critical for advancing our understanding of AF mechanisms and for
developing new AF therapies in the future.
In Chapter 3, we demonstrated that Ca2+-handling abnormalities occurring sec-
ondary to AF remodeling could underlie the action potential duration (APD) al-
ternans observed during atrial pacing of AF-cardioverted patients. In this chapter,
we present our investigation on the effects of Ca2+-driven alternans (CDA) on ar-
rhythmia initiation. For this study, we utilized a realistic 3D computer model of
the human atria incorporating the cellular mechanisms identified in Chapter 3. We
demonstrate that elevated CDA propensity leads to increased arrhythmia vulnera-
bility due increased repolarization heterogeneity resulting from discordant alternans.
Our findings suggest that CDA secondary to AF-induced electrical remodeling may
play a significant role in the initiation of AF.
4.2 Methods
4.2.1 Human atria model
We used an anatomically realistic computer model of the human atria to investi-
gate the effect of increased CDA propensity on arrhythmia initiation and maintenance
in the atria. Model geometry was based on the Visible Human female dataset [92],
which has been used previously to investigate mechanisms of arrhythmogenesis related
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to AF [93]. To explore the effects of CDA secondary to AF-induced electrical remod-
eling on arrhythmogenesis, we tested two atria with chronic AF-induced structural
and electrical remodeling. Structural changes were modeled by scaling anisotropic
heterogeneous tissue conductivities to produce an average conduction velocity (CV)
of 40 cm/s (Table 4.1), consistent with slowed conduction in chronic AF [94]. Electri-
cal remodeling was based on a human atrial action potential (AP) model described
by Grandi et al., which produced APD shortening as observed in chronic AF [40].
These parameters led to alternans onset at fast pacing rates in the first atria model,
ALTfast. The second atria model,ALTslow, incorporated an additional remodeling fea-
ture: reduction of ryanodine receptor (RyR2) inactivation rate by 50%, which we
showed in Chapter 3 results in increased propensity to CDA, matching alternans
onset at slower pacing rates observed clinically [18] (Fig. 4.1A, see Section 4.5.1). Re-
gional AP heterogeneity between the left atrium (LA) (Fig. 4.1B) and the right atrium
(RA) (Fig. 4.1C) were included in both ALTfast and ALTslow models (Fig. 4.1D), as
described by Grandi et al. [40].
4.2.2 Numerical methods
A monodomain formulation was used to represent electrical propagation through-
out the human atria model [23]. The monodomain and AP model equations were
solved together by a finite element approach using the Cardiac Arrhythmia Research
Package (CARP; Cardiosolv, LLC) [24, 48]. A time step of 20 µs was used for all
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Figure 4.1: Human atria model
A. Single cell APD restitution for ALTfast (solid line) and ALTslow (dashed line)
AP models, using LA (green) or RA (orange) parameter values for chronic AF
(cAF) from Ref. [40]. B. LA cell APs for the ALTfast and ALTslow models at
different pacing cycle lengths (CLs). C. RA cell APs for the ALTfast and ALTslow
models at different pacing CLs. D. LA and RA regions in the human atria model.
E. Stimulus locations. F. Detection of filaments during arrhythmia.
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simulations. The mesh contained 2198425 nodes and 3005729 elements with a mean
edge length of 330 µm.
4.2.3 Arrhythmia induction protocol
An S1–S2 pacing protocol was used to assess arrhythmia vulnerability due to an
ectopic beat. Dynamic pacing was performed to reach the S1 pacing CL (300 ms).
All nodes in the model were first initialized using steady-state values from a single
cell paced at 750-ms CL. The atria were paced from the SAN region at 750-ms CL
for 20 beats (Fig. 4.1E), and then for 32 beats at each subsequent pacing CL (500 ms
to 300 ms in 50-ms decrements). After the 16th even or odd beat at 300-ms CL
pacing (S1), we ceased SAN pacing and applied an ectopic stimulus (S2) to one of
eight locations in pulmonary veins at eleven different coupling intervals (CIs), ranging
from 250 ms to 300 ms. Figure 4.1E shows location of the S2 stimuli, in the right
superior pulmonary veins (RS0–3) or the right inferior pulmonary veins (RI0–3).
Post-S2 activity was simulated for 2 s or until activity terminated, whichever came
first.
4.2.4 Quantification of APD alternans
APD was calculated as the time from maximal upstroke velocity to 90% repolariza-
tion of transmembrane potential (Vm) from phase 2 amplitude. Alternans magnitude
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was quantified as the mean change in APD from beat to beat over the last 10 pairs
of beats (11 beats total) at a given pacing CL [18].
4.3 Results
4.3.1 Discordant alternans promotes reentry after
an ectopic beat
We examined the effect of increased propensity to CDA on arrhythmia vulner-
ability in 3D models of the human atria incorporating both electrical (shortened
AP) and structural (decreased conductivity) remodeling associated with AF. Two
human atria models were compared: ALTfast, with alternans only at fast pacing rates
(CL≤ 270 ms), and ALTslow, with alternans at slower pacing rates (CL≤ 400 ms) re-
sulting from reduced RyR2 inactivation (see Section 4.2.1). An S1–S2 pacing protocol
was performed in both models to induce arrhythmia. During S1 pacing at 300-ms
CL, large-magnitude discordant APD alternans was evident in ALTslow but was ab-
sent in ALTfast (Fig. 4.2A). Accordingly, the distribution of repolarization times in the
ALTfast model remained the same from beat to beat. In contrast, the distribution and
spatial pattern of repolarization times in the ALTslow model changed noticeably be-
tween the even and odd beats (Fig. 4.2B). In particular, the even beat in the ALTslow
model displayed the most heterogeneity, with areas of early (purple) and late (red)
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Figure 4.2: Discordant APD alternans during S1 pacing
A. APD alternans magnitude. Regions of opposite phase are shown in different
colors (red vs. blue). B. Time to 90% repolarization after even (left) and odd
(right) paced beats. Top: ALTfast. Bottom: ALTslow.
repolarization separated by closely spaced isochrones.
When an S2 beat was delivered to the right superior pulmonary vein (RSPV)
at a CI of 280 ms after the even beat, refractory tissue around the pulmonary vein
blocked conduction towards the LA in both ALTfast and ALTslow models (Fig. 4.3).
The wavefronts propagated first into the RA and eventually back around the RSPV
into the LA (Fig. 4.3A). In ALTfast, propagation around the RSPV was fast, resulting
in the wavefront colliding with the refractory tail of the S2 wave and terminating
the reentrant activity (Fig. 4.3B top). In ALTslow, however, propagation towards
the RA was fast while propagation around the RSPV was slow, due to the steep
repolarization gradients from the previous S1 beat (Fig. 4.2B). This resulted in the
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Figure 4.3: Induction of reentry by an S2 stimulus
A. Activation time maps after an S2 stimulus was delivered at RS0 (see Fig. 4.1E),
at a CI of 280 ms following an even S1 beat. B. Vm maps showing conduction block
and reentry following S2 stimulus in panel A. Top: ALTfast. Bottom: ALTslow.
wavefront reaching the RSPV later than in ALTfast, after refractory tissue from the
S2 wave had already recovered, thus allowing reentry to continue around the RSPV
for several cycles (Fig. 4.3B bottom).
4.3.2 CDA leads to increased arrhythmia
vulnerability
The S1–S2 protocol was repeated for eight different stimuli locations in the right
pulmonary veins, at 11 different CIs following an even or odd S1 beat, for both the
ALTfast and ALTslow models (352 atrial simulations total, Fig. 4.4). As expected,
outcomes for ALTfast simulations were identical following even and odd beats, since
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repolarization patterns did not change from beat to beat (Figs. 4.4A and 4.2A). Most
ectopic beat locations and CIs did not produce reentrant activity in ALTfast. Ec-
topic beats at three locations (RS0, RS1, and RS3) resulted in post-S2 reentry over a
narrow range of CIs, which did not sustain for more than one reentrant cycle. In con-
trast, all eight ectopic beat locations produced post-S2 reentrant activity in ALTslow
(Fig. 4.4B). After the odd beat, any post-S2 activity in ALTslow terminated after one
reentrant beat, as in the ALTfast simulations. After the even beat, however, more
than one reentrant cycle was induced at two S2 stimulus locations in ALTslow (RS0
and RS1). At RS0, three CIs resulted in reentry that broke up into multiple wavelets
after about three cycles. In one simulation (RS0, CI=270 ms), arrhythmia sustained
>2 s after the S2 stimulus, during which the initial reentry around the RSPV even-
tually terminated and an unstable scroll wave later appeared and meandered in the
RA. These results demonstrate that repolarization heterogeneity induced by CDA
resulted in increased atrial vulnerability to arrhythmia induction by ectopic beats.
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Figure 4.4: Vulnerability of atria to reentry
Summary of results for ALTfast (A) and ALTslow (B) simulations. When post-
S2 reentrant activity lasted longer than three cycles, arrhythmia broke up into
multiple wavelets (labeled “3+”). The simulation indicated by the white plus
sign had arrhythmia lasting longer than 2 s.
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4.4 Discussion
APD alternans has been observed at pacing rates as slow as 100–120 beats per
minute in the atria of cardioverted AF patients undergoing electrophysiological study [17].
In Chapter 3, we examined the underlying cellular mechanisms driving APD alter-
nans in remodeled atrial myocytes, showing that altered RyR2 kinetics and down
regulation of L-type Ca2+ current induced by AF remodeling can lead to CDA at
slower pacing rates. In this study, we addressed whether alternans occurring due
to the Ca2+-dependent mechanisms we identified previously can affect arrhythmia
vulnerability in the atria.
Our results demonstrate that CDA occurring at slow pacing rates in remodeled
atrial myocytes can increase the vulnerability of the atria to reentry. In a biophysically
detailed, anatomically realistic model of the human atria, we found that shortened
APD and reduced CV alone were not sufficient to render the atria vulnerable to
reentry initiation by an ectopic beat from the pulmonary veins. In contrast, when
CDA propensity was increased in the atria via reduction in RyR2 inactivation (see
Section 3.3.4), reentry could be induced at two out of the eight right pulmonary vein
locations tested. CDA created a vulnerable substrate defined by steep repolarization
gradients, which allowed these ectopic beats to induce reentry. This mechanism might
explain clinical observations of premature beats initiating AF in patients during slow
pacing rates when APD alternans was present [18].
This study establishes a mechanistic link between Ca2+ handling instability, alter-
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nans, and arrhythmia initiation in a model of the human atria. Previous investigations
using computational modeling have addressed the role of alternans on arrhythmia ini-
tiation but in different contexts. Gong et al. tested the effect of electrically driven
alternans on AF initiation in a computer model of paroxysmal AF, in which upregu-
lation of L-type Ca2+ current (ICaL) caused in APD prolongation and steepening of
APD restitution slope [95]. However, APD and ICaL are unchanged in paroxysmal
AF [13] and are decreased in chronic AF [96], so the clinical relevance of their findings
may be limited. The mechanisms explored in this study stem from a more current
understanding of the role of Ca2+ handling abnormalities in human AF [25] and
may thus provide better insight into the pathophysiological mechanisms underlying
arrhythmogenesis in patients.
These findings demonstrate that CDA can help initiate arrhythmia in the atria.
Identifying atrial alternans in patients may provide valuable insight into the arrhyth-
mogenic substrate, but it remains to be determined whether CDA also plays a role
in helping to maintain arrhythmia. This question has important implications for the
understanding and treatment of AF and will be addressed in Chapter 5.
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4.5 Appendix
4.5.1 Human atria model
Membrane kinetics in the human atria model was represented by the modified
Grandi-Pandit-Voigt human atrial action potential model (see Section 3.5.1.1). Rule-
based fiber orientation was included in the human atria model to produce realistic
activation patterns [97]. Anisotropic conductivity ratios varied regionally as specified
by Krueger et al. [97], with conductivities scaled uniformly to produce slow conduction
consistent with measurements in AF patients [94] (Table 4.1).
96
CHAPTER 4. ARRHYTHMIA VULNERABILITY























gl 0.27225 0.17622 0.64


















gl 0.6975 0.45284 1.1
sinoatrial
node






Alternans, the beat-to-beat alternation in cardiac electrical signals, has been ob-
served in the atria of cardioverted patients who experience atrial fibrillation (AF) [17],
but its implications for arrhythmogenesis and AF treatment have not been fully ex-
plored. Alternans resulting from steep cardiac restitution properties can promote
both initiation and termination of arrhythmias, by increasing the frequency of wave-
break but at the same time destabilizing spiral waves [98]. Understanding the effects
of atrial alternans on both the initiation and termination of arrhythmia is needed to
enhance our understanding of AF mechanisms and aid in the development of new AF
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treatments.
Our results in Chapter 4 demonstrate a plausible mechanistic link between atrial
alternans and AF initiation, arising from the Ca2+ handling mechanisms explored
in Chapter 3. In this chapter, we investigate the influence of Ca2+-driven alternans
(CDA) on arrhythmia complexity and persistence, utilizing the same computer model
of the human atria described in Chapter 4. Results show that increased propensity to
CDA leads to more frequent wavebreak and increased arrhythmia complexity. Fur-
thermore, frequent wavebreak in CDA-prone atria also helps to sustain arrhythmia.
Our findings suggest that CDA in the atria promotes arrhythmia maintenance by
increasing arrhythmia disorganization and complexity and that atrial alternans may
present a promising therapeutic target for AF.
5.2 Methods
5.2.1 Human atria model
The human atria model used in this study was identical to that used in Chapter 4
and described in detail in Sections 4.2.1 and 4.5.1. Briefly, two versions of the hu-
man atria model were compared to assess the effects of CDA. Both versions included
AF-induced electrical and structural remodeling that resulted in action potential du-
ration (APD) shortening and decreased conduction velocity (CV). In the first version
(ALTfast), CDA occurred only at fast pacing rates (cycle length (CL)≤ 270 ms). In
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the second version (ALTslow), CDA began at slow pacing rates (CL≤ 400 ms) as a con-
sequence of a 50% decrease in ryanodine receptor (RyR2) inactivation rate constant
(kiCa), as detailed in Chapter 3.
5.2.2 Numerical methods
A monodomain formulation was used to represent electrical propagation through-
out the human atria model [23]. The monodomain and action potential (AP) model
equations were solved together by a finite element approach using the Cardiac Ar-
rhythmia Research Package (CARP; Cardiosolv, LLC) [24, 48]. A time step of 20 µs
was used for all simulations. The mesh contained 2198425 nodes and 3005729 ele-
ments with a mean edge length of 330 µm.
5.2.3 Arrhythmia induction protocol
To compare arrhythmia characteristics between ALTfast and ALTslow models, we
induced arrhythmia using a dynamic pacing protocol similar to one used clinically [18].
All nodes in the model were initialized using steady-state values from a single cell
paced at 750-ms CL. The atria were paced from the SAN region at 750-ms CL for 20
beats (Fig. 4.1E), and then for 32 beats at each subsequent pacing CL: from 500 ms
to 300 ms in 50-ms decrements, then from 290 ms to 250 ms in 10-ms decrements.
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5.2.4 Quantification of APD alternans
APD was calculated as the time from maximal upstroke velocity to 90% repolariza-
tion of transmembrane potential (Vm) from phase 2 amplitude. Alternans magnitude
was quantified as the mean change in APD from beat to beat over the last 10 pairs
of beats (11 beats total) at a given pacing CL [18].
5.2.5 Filament dynamics
Phase singularities (PSs) are points where the phase of the AP is undefined,
occurring at locations of wavebreak or at the tip of a reentrant spiral wave. In 3D, PSs
form the vortex filaments of reentrant scroll waves. To robustly detect filaments in our
simulations despite variations in AP morphology [99], we developed a novel method
for filament localization, which involves constructing phase maps from activation
times (see Section 5.5.1). To gain insight into filament dynamics, we tracked at 1-
kHz resolution each filament’s birth, death, and interactions with other filaments,
splitting (bifurcation) or merging (amalgamation) to form new filaments. A filament
tree (FT) was defined as the set of filaments that interact with each other over time.
Spurious filaments associated with brief wavebreak were not included in the dataset to
allow interpretation of the temporal branching structure of filament interactions. An
example snapshot of filament localization during arrhythmia is shown in Figure 4.1F.
Details on filament detection can be found in Section 5.5.1.
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5.2.6 Statistical analysis
Adjusted box-whisker plots were used to compare skewed distributions and detect
outliers [100]. Chi-squared tests of independence without correction were used to as-
sess differences in filament interaction [101]. The Mann-Whitney U statistic was used
to test for differences in distribution location, with p < 0.05 considered significant.
Pearson’s correlation coefficient r was used to quantify the linear dependence between
variables. Significance of Pearson correlations and their differences (∆r) was assessed
using a percentile bootstrap method to estimate 95% confidence intervals (Wilcox-
Muska confidence intervals) in the independent case, and using the HC4 method in
the overlapping dependent case [102]. These methods have been shown to perform
well under conditions of nonnormality and heteroscedasticity [103].
5.3 Results
5.3.1 CDA leads to increased arrhythmia
complexity
We investigated the effect of CDA on arrhythmia complexity in the ALTfast and
ALTslow atria models. Complexity was quantified by tracking filaments, which are
the organizing centers of scroll waves where PSs occur (see Section 5.2.5). We paced
the atria from the SAN region at progressively faster rates to induce arrhythmia.
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Figure 5.1: Discordant APD alternans and filaments during fast pacing
A. APD alternans magnitude in ALTfast (top) and ALTslow (bottom) during pac-
ing at 270-ms CL. Regions of opposite phase are shown in different colors (red vs.
blue). B. Nodal surfaces (black) and filaments (color) in ALTslow during 260-ms
CL pacing. Snapshots show filament locations at different times after a paced
beat from sinoatrial node (SAN) region. Filaments from the first four beats are
shown in different colors on the same snapshot for comparison.
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Discordant APD alternans developed at 270- and 350-ms CL pacing in ALTfast and
ALTslow, respectively. During 270-ms CL pacing, several discordant regions were
present in both models, but APD alternans magnitude was noticeably larger in
ALTslow (red and blue regions, Fig. 5.1A). As pacing rate increased to 260-ms CL,
this repolarization heterogeneity in ALTslow led to wavebreak and filament formation
near nodal lines, where regions with alternans of opposite polarity meet (Fig. 5.1B).
Filaments appeared earlier (during 270-ms CL pacing) and were present longer in
the ALTslow model (Fig. 5.2A). During arrhythmia (i.e. at time points when filaments
were present), ALTslow tended to have significantly more filaments than ALTfast (me-
dian was 2 and 6 filaments for ALTfast and ALTslow, respectively), indicating that
CDA increased the complexity of arrhythmia (Fig. 5.2B and 5.1).
We investigated two possible contributors to the increased number of filaments
in ALTslow: additional new filament formation or increased filament duration. Fig-
ure 5.2C compares new filament formation during fast pacing (270-ms to 250-ms CL)
in ALTfast and ALTslow. New filaments appeared steadily during 260-ms and 250-ms
CL pacing in ALTslow but slowed in ALTfast after about 10 beats. Thus, to a large de-
gree, new filament formation accounted for the increased number of filaments present
in ALTslow.
We also compared differences in individual filament persistence during fast pacing.
The total number of filaments during this pacing period was 527 and 3197 for ALTfast
and ALTslow, respectively. Short-lived filaments dominated both ALTfast and ALTslow
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Figure 5.2: Filament dynamics during fast pacing
A. Heat maps of the number of distinct filaments present over time in ALTfast
(left) and ALTslow (right). B, D, and E: Histograms and adjusted box-whisker
plots for ALTfast (red) and ALTslow (blue). Green crosses indicate outliers.
B. Number of filaments during arrhythmia (time points when filaments were
present). C. Cumulative number of new filaments formed in ALTfast (solid line)
and ALTslow (dotted line) at pacing CLs of 270 ms (red), 260 ms (blue), and
250 ms (green). D. Filament duration. E. FT duration.
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Table 5.1: Filament and FT metrics during fast pacing
Mean values for the ALTfast and ALTslow simulations are reported for
all metrics except for duration of arrhythmia, number of filaments, and
number of FTs. Differences in distribution between the human atria model
with alternans onset at fast rates (ALTfast) and human atria model with
alternans onset at slow rates (ALTslow) simulations were assessed with the
Mann-Whitney U statistic, with p < 0.05 considered significant.
ALTfast ALTslow U p
Duration of arrhythmia (ms) 3328 15894 - -
Number of filaments
during arrhythmia
4.50 7.07 16111484.5 <10-6
Number of filaments 527 3197 - -
Filament duration (ms) 28.4 35.2 808583 0.14
Number of FTs 198 976 - -
FT duration (ms) 56.0 84.8 82880.5 0.002
FT composition metrics
Mean filament duration (ms) 33.8 40.8 92282.5 0.32
Number of filaments 2.66 3.28 84377.5 <0.001
Max filament duration (ms) 47.8 63.3 84714 0.006
Sum of filament durations (ms) 75.6 115.3 82306.5 <0.001
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Figure 5.3: Phase singularity density during fast pacing
A. Locations of PS points in ALTfast (left) and ALTslow (right) during pacing at
CLs of 270 ms (red), 260 ms (blue), and 250 ms (green). B. Mean density of
points at which PSs occurred over time in the LA (purple) and RA (orange) for
ALTfast (circles) and ALTslow (x’s).
filament duration distributions (median duration was 17 ms for both simulations,
Fig. 5.2D), and the difference in filament durations was not significant (5.1). How-
ever, the distribution of filament durations in ALTslow was more right-skewed than in
ALTfast (Fig. 5.2D, top). Furthermore, nine of the fourteen long-lived filament out-
liers in the ALTslow simulation persisted longer than 400 ms, whereas only one of the
six long-lived outliers did so in the ALTfast simulation. Thus, long lasting filaments
occurred more frequently during fast pacing in atria with increased propensity to
CDA.
Regional differences in the density of points at which PSs occurred over time were
observed during fast pacing. In ALTfast, there was higher PS density in the left atrium
(LA) than in the right atrium (RA) (Fig. 5.3). In ALTslow, PS density was higher in
the RA than in the LA except during 250-ms CL pacing, when the reverse was true.
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This was perhaps due to shorter APD in the LA (Fig. 4.1A), which allowed the LA
to support more scroll waves.
5.3.2 CDA leads to increased arrhythmia
persistence
New filaments can form when wavebreak creates new scroll waves, or when pre-
existing scroll waves interact or break up, resulting in the bifurcation and/or amal-
gamation of filaments. The proportion of filaments that formed from preexisting
filaments during fast pacing (270-ms to 250-ms CL) was higher for ALTslow (0.57
vs. 0.51, χ2=6.02, p = 0.014). Likewise, the proportion of filaments that were in-
volved in forming new filaments was also higher for ALTslow (0.55 vs. 0.50, χ
2=3.87,
p = 0.049). This suggested that increased filament interaction contributed to ar-
rhythmia maintenance in ALTslow.
To further characterize the dynamics of filament formation and persistence, we
analyzed FTs, defined as the set of filaments that interact with each other spatiotem-
porally. During fast pacing, there were 198 and 976 total FTs in ALTfast and ALTslow,
respectively. In both simulations, most FTs were short-lived (median duration was
37.5 ms and 52 ms for ALTfast and ALTslow, respectively) (Fig. 5.2E), but FT dura-
tion tended to be longer in ALTslow (Table 5.1). The distribution of FT durations in
ALTslow was more right-skewed, with many more long-duration FT outliers (Fig. 5.2E,
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Figure 5.4: Examples of FTs during fast pacing
Graphs of FT branching structure from two example FTs in ALTfast (A) and
ALTslow (B) simulations. Filament duration is indicated by node colors; time is
not drawn to scale. Trajectories of FTs from panels A and B are shown in C and
D, respectively.
top).
Two examples of long-lived FT outliers from ALTfast and ALTslow are presented
in Figure 5.4. Although the branching patterns of FTs could be quite complex,
several FTs displayed an overall linear structure (Fig. 5.4A–B), indicating that each
FT was dominated by a single scroll wave. The lifetimes of these scroll waves were
often punctuated by wavebreak, resulting in the branching of a single filament into
several short-lived filaments (<25 ms). The ALTfast scroll wave meandered around
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Table 5.2: Pearson correlation analysis of FTs
Pearson correlations between FT duration and FT composition metrics
for the ALTfast and ALTslow simulations and the difference in ALTfast and
ALTslow correlations (∆r) were assessed during fast pacing (CLs of 270 ms
to 250 ms). Confidence intervals at 95% are shown in brackets.
ALTfast ALTslow ∆r
Mean duration 0.37 [0.27 0.51] 0.34 [0.29 0.43] 0.03 [-0.11 0.18]
Number of filaments 0.61 [0.48 0.74] 0.70 [0.64 0.75] -0.08 [-0.22 0.05]
Maximum duration 0.96 [0.92 0.98] 0.83 [0.80 0.89] 0.13 [0.06 0.17]
Sum of durations 0.92 [0.87 0.96] 0.95 [0.93 0.96] -0.03 [-0.08 0.02]
the left atrial roof and lasted 540 ms (Fig. 5.4C). During its lifetime, one wavebreak
occurred, separating the FT into two long-duration filaments (>100 ms, Fig. 5.4A).
The ALTslow scroll wave meandered in a limited region on the right atrial wall near
the superior vena cava and lasted 1043 ms, substantially longer than the ALTfast
FT (Fig. 5.4D). Four wavebreak episodes occurred, separating the ALTslow FT into
five long-duration filaments (>75 ms, Fig. 5.4B). Thus, these patterns suggested that
wavebreak contributed to increased persistence of scroll waves in ALTslow as compared
to ALTfast.
In order to evaluate how representative these FTs were of general differences in FT
composition between ALTfast and ALTslow, we assessed four different FT composition
metrics: mean filament duration, number of filaments, maximum filament duration,
and sum of filament durations. The averages of each of these metrics over all FTs
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Table 5.3: Comparison of FT composition correlations
Pearson correlation between FT duration and mean filament duration was
compared to the correlation between FT duration and other FT composition
metrics for the ALTfast and ALTslow simulations during fast pacing (CLs of
270 ms to 250 ms). Confidence intervals at 95% are shown in brackets.
ALTfast ALTslow
Number of filaments 0.25 [-0.15 0.64] 0.36 [0.14 0.58]
Maximum duration 0.59 [0.44 0.74] 0.49 [0.37 0.62]
Sum of durations 0.55 [0.24 0.86] 0.61 [0.48 0.74]
within a simulation, and statistical tests of the differences between simulations, are
reported in Table 5.1. For all FT composition metrics, ALTslow tended to have larger
values than ALTfast, with statistical significance in all metrics except mean filament
duration. Not surprisingly, these metrics were also positively correlated with longer
FT duration (Table 5.2).
Figure 5.5 illustrates the relationship between FT duration and FT composition
metrics. Although a modest linear trend was present in the relationship between FT
duration and mean filament length, FTs with the longest duration deviated signifi-
cantly from this trend, having very short mean filament duration (Fig. 5.5, column 1).
FT duration was more strongly correlated with the total number of filaments per FT
(column 2), with the maximum filament duration within each FT (column 3), and
with the sum of filament durations within each FT (column 4) (Table 5.3).
These statistical trends were consistent with observations in the two example
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Figure 5.5: FT composition during fast pacing
Top: ALTfast. Bottom: ALTslow. Left to right: mean filament duration, number
of filaments, maximum filament duration, and sum of filament durations. Linear
best fit lines and Pearson correlation coefficients are shown in each plot.
FTs from Figure 5.4. In general, the longest-lived FTs were composed of a few
long-duration filaments (>75 ms) preceded and/or followed by the numerous short-
duration filaments (<25 ms) that formed during wavebreak. Therefore, mean filament
duration was weakly correlated with FT duration, but the number of filaments and
the sum of filament durations were strongly correlated with FT duration (Table 5.2
and Fig. 5.5). Additionally, maximum filament duration was more strongly correlated
with FT duration in ALTfast than in ALTslow (r=0.13 [0.06, 0.17], Table 5.2). This
was because long-lived FTs in ALTfast tended to be composed of only one or two
long-duration filaments, while long-lived FTs in ALTslow tended to be composed of
many long-duration filaments, due to the occurrence of several wavebreak episodes
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in each FT’s lifetime. Thus, the above results demonstrate that increased wavebreak
resulting from increased propensity to CDA in ALTslow helped to sustain arrhythmia
in the remodeled atria during fast pacing.
5.4 Discussion
Many remodeling changes secondary to AF are profibrillatory, leading to a cycle
of worsening AF susceptibility over time (the idea that “AF begets AF”). In partic-
ular, shortened APD and decreased CV promote reentry and can thus stabilize scroll
waves to help maintain AF [104]. Since alternans promotes breakup and destabilizes
scroll waves, the initiation and persistence of the arrhythmia in the presence of alter-
nans depends critically on restitution properties [98]. In Chapter 3, we showed that
APD alternans likely arises from Ca2+ handling instabilities caused by altered RyR2
kinetics in atrial myocytes. In Chapter 4, we showed that CDA can increase the
vulnerability of the atria to reentry. In this chapter, we addressed the profibrillatory
nature of CDA, investigating whether elevated CDA propensity ultimately promotes
or prevents the maintenance of arrhythmia in the atria.
Our results show that CDA-prone atria display more frequent wavebreak at fast
pacing rates, resulting in more complex arrhythmia. Frequent wavebreak at fast
pacing rates was also associated with longer-duration scroll waves, suggesting that
increased wavebreak due to Ca2+ handling instability ultimately led to increased
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arrhythmia persistence, by producing more scroll waves that helped maintain the
arrhythmia. Thus, preventing alternans by targeting the Ca2+ handling mechanisms
underlying it may have significant antiarrhythmic benefit.
Three-dimensional computer models of atrial anatomy and electrophysiology pro-
vide a powerful tool for dissecting the mechanisms involved in AF arrhythmogene-
sis [19,105]. Previous computational studies have examined the arrhythmogenic role
of decreased wavelength due to AF remodeling, namely shortened APD and/or de-
creased CV [82, 93, 106]. The mechanisms explored in this work stem from a more
current understanding of the role of Ca2+ handling abnormalities in human AF [25]
and may thus provide better insight into the pathophysiological mechanisms under-
lying arrhythmogenesis in patients.
Increased propensity to CDA at slower pacing rates increased the complexity and
persistence of arrhythmias occurring during fast pacing. Arrhythmias were character-
ized by unstable scroll waves which meandered over large areas and frequently broke
up, similar to those observed clinically with electrocardiogram imaging [16]. Fre-
quent wavebreak due to underlying Ca2+ instability helped perpetuate arrhythmia in
the remodeled atria, supporting the view that abnormal Ca2+ handling may play a
significant role in the AF substrate of patients with elevated alternans propensity.
The main mechanisms in AF are much debated, with one of the central controver-
sies being whether AF occurs primarily due to organized reentrant drivers or multiple
wavelets [107]. Although several lines of evidence suggest that organized reentrant
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drivers underlie arrhythmias in many AF patients and may be targeted to effectively
terminate arrhythmia [108], patients with longer-duration continuous AF usually do
not respond to ablation therapy [16]. Although exploring AF termination was be-
yond the scope of this study, we speculate that the disorganized, multiple-wavelet
arrhythmia occurring due to increased CDA propensity in our model would be more
difficult to terminate. Thus, CDA may reflect some of the progressive changes that
occur in the underlying substrate during long-standing AF which make standard
therapies ineffective. However, in the present study, we modeled fibrotic changes
due to AF as a global decrease in tissue conductivity, without taking into account
specific patterns of structural heterogeneity that can influence arrhythmia organiza-
tion [109–111]. Further work is needed to determine how interaction of structural and
functional mechanisms affect arrhythmia organization in AF [112–114], particularly
in patients that do not respond to ablation therapy.
Recent efforts to identify mechanisms and potential pharmacological targets in
AF have shown that suppressing CDA may have significant antiarrhythmic benefits.
Ca2+ transient alternans and abnormal Ca2+ release events have been observed in
mouse [62] and canine [115] models of AF. Treatment with S107 in mouse [62] and
dantrolene in canine hearts [116] appeared to stabilize RyR2 and effectively reverse
abnormal changes in Ca2+ handling to prevent arrhythmia. Our results suggest that
similar mechanisms may be at play in human AF as well, since increased propensity to
CDA driven by RyR2 dysfunction led to increased arrhythmia vulnerability, complex-
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ity, and persistence in our model. Recent evidence for this comes from experiments
in human atrial myocytes of control and AF patients, which identified a link between
adenosine signaling, alternans, and Ca2+ handling instability, potentially mediated by
protein kinase A regulation of RyR2 [117]. However, the main mechanisms of RyR2
regulation are extremely complex [118] and controversial [69]. Further work needs to
be done to clarify the mechanisms of RyR2 regulation and to explore the antiarrhyth-
mic benefits of RyR2-targeting therapies that address the dual role of Ca2+ as both
an initiating trigger and vulnerable substrate in AF [33].
Although the present study focused on the role of alternans in chronic AF, el-
evated propensity to APD alternans has been observed in paroxysmal AF patients
as well [18, 30, 32]. However, the mechanisms underlying alternans may differ, since
Ca2+ handling is altered between paroxysmal and chronic AF [13]. In paroxysmal AF,
evidence suggests that SK channels [119], acetylcholine-activated K+ current [120],
and late Na+ current [121] may play a more prominent role in alternans propen-
sity and arrhythmogenesis. Given the arrhythmogenic implications of APD alternans
presented in this and other studies, these differences in the fundamental mechanisms
underlying APD alternans in paroxysmal versus chronic AF underscore the need for
further research on the diversity of AF mechanisms [11], in order to develop better
targeted, patient-specific therapies.
In conclusion, alternans driven by Ca2+ handling abnormalities secondary to AF-
induced remodeling appears to play a significant role in arrhythmia maintenance.
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We found that increased repolarization heterogeneity due to discordant CDA led to
increased arrhythmia complexity and persistence in a computer model of the hu-
man atria. The mechanisms explored in this study may be particularly relevant to
long-standing or permanent AF cases that are unresponsive to standard therapies.
Consideration of these mechanisms will be important for the development of new
approaches to AF treatment in the future.
5.5 Appendix
5.5.1 Filament calculations and filtering
We developed an algorithm to find filaments using activation time data. When Vm
of a particular node, ni, crossed above the activation threshold (−40 mV), an activa-
tion time value (ATV) of 1 was assigned to ni for that time point. Any activations
occurring within 50 ms of a previous activation at the same node were discarded.
To generate smooth activation wavefronts, if any adjacent node (sharing the same
element) activated within the 20 ms after the activation of ni, then ni was assigned
an ATV of 1 from the time of its own activation up to and including the time of the
last activation of an adjacent node. For the subsequent 20 ms, the ATV at ni was
decremented by 0.05/ms. ni was assigned an ATV of 0 at all other times. Phase
singularities were located as described by Iyer and Gray [122]. The phase of ni (θni)
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at each time point (t) was computed by the following function:
θni (t) = arctan2 (ATVni (t+ τ)− ATV∗,ATVni (t)− ATV∗) (5.1)
where τ =1 ms and ATV*=0.5. The choice of these parameters followed naturally
from the prescribed time course of the ATV variable after activation. PSs were identi-
fied by calculating the line integral of the phase around every face in the model [123].
All nodes of any face containing a PS (line integral=±2π) were assigned as being
associated with a PS. A filament was identified as the set of adjacent nodes associated
with PSs.
Filaments were tracked spatiotemporally at a resolution of 1 kHz, as described
by Clayton and Holden [124]. If only one filament from the current time step shared
nodes with or was adjacent to exactly one filament from the previous time step, it
was considered the same filament. However, when a filament shared nodes with or
was adjacent to more than one filament from the previous time step, the filament in
the current time step was considered a new filament generated from the merging of
the filaments of the previous time step. Conversely, when multiple filaments shared
nodes with or were adjacent to a filament from the previous time step, the filaments
in the current time step were considered new filaments generated from the splitting
of the filament in the previous time step. A FT was defined as the set of filaments
that interacted over time.
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To simplify analysis of filament populations, we removed spurious filaments, de-
fined as any filament lasting <6 ms which did not arise from previous filaments and
did not generate new filaments. At the beginning or end of a FT, these were associ-
ated with complex conduction block patterns that were not of interest in this study.
In the middle of a FT, these were often associated with minute wavebreaks. When
multiple filaments merged into one, or one filament split into multiple, spurious fil-
aments were removed from the set of multiple filaments such that the longest-lived
filament (whether spurious or not) always remained. In the event that at this branch-
ing point, all but one filament was removed, the filament before and after this point




In this thesis work, we investigated both the mechanistic underpinnings and the
arrhythmogenic consequences of atrial alternans related to atrial fibrillation (AF). Us-
ing biophysically detailed computer models of the human atria, we have shown that
altered Ca2+ release is mechanistically linked to increased arrhythmia risk via alter-
nans. In Chapter 3, we presented a detailed investigation into the AF-related cellular
mechanisms underlying action potential duration (APD) alternans occurring at clin-
ically observed pacing rates. We showed that decreased ryanodine receptor (RyR2)
inactivation leads to Ca2+ cycling instabilities that result in Ca2+-driven alternans
(CDA). In Chapter 4, we evaluated the effects of these mechanisms on arrhythmia
vulnerability in a realistic human atria model. Simulations demonstrated that repo-
larization heterogeneity resulting from discordant CDA renders the atria inducible to
sustained reentry from a properly timed and located ectopic beat. Lastly, in Chap-
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ter 5, we assessed the influence of CDA on arrhythmia complexity and persistence in
the human atria model. We found that CDA led to more frequent wavebreak, which
resulted in more complex and longer-lasting arrhythmia. Thus, alternans appears to
have a significant impact on the AF substrate, influencing both the initiation and
maintenance of reentrant arrhythmia in the atria.
These findings have several important implications. First, these simulations pre-
dict that stabilizing the RyR2 through drug targeting should provide significant
antiarrhythmic benefit in human, as has been previously shown in animal models.
Experiments to characterize the effects of RyR2-targeting drugs in human atrial my-
ocytes will be needed to help validate modeling predictions and strengthen the argu-
ment for developing these drugs to treat AF. Second, our findings suggest that CDA
can lead to changes in arrhythmia organization in the atria and may thus impact
the efficacy of currently available AF treatments. Improving methods to detect and
characterize atrial alternans in patients may aid in the development of personalized,
mechanism-based therapies. Lastly, we have demonstrated the utility of biophysi-
cally detailed computer models for providing valuable insights into clinically relevant
mechanisms of arrhythmogensis. This type of analysis, spanning the cellular to organ
scale, would be extremely difficult to achieve in experimental settings and is at present
only possible using a computational approach. As experiments uncover new insights
into the complex regulation of RyR2 in the atria, incorporation of such findings into
computer models will advance the understanding and treatment of AF in the future.
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Conduction block and defibrillation
with high-frequency electric fields
This section presents additional work that was completed during the Ph.D. It has
been published in Science Translational Medicine [125] and Heart Rhythm [126].
A.1 Introduction
Ventricular fibrillation (VF) is a lethal arrhythmia which currently can only be
treated by brief, high-voltage direct current (DC) or biphasic shocks. Though effec-
tive, these strong electric shocks damage the myocardium and cause pain. Alternative
methods of defibrillation are needed.
The goal of this study was to explore the use of high-frequency alternating current
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(HFAC) electric fields to block conduction and thereby terminate arrhythmia in the
ventricles.
A.2 Methods
A.2.1 Rabbit ventricular model
Simulations were performed using a previously validated anatomical model of rab-
bit ventricles incorporating realistic geometry and fiber orientation [127–129]. A bido-
main representation was used to model the electrical behavior of the tissue, including
its response to external field stimulation [130]. Membrane kinetics were represented by
the Luo-Rudy ionic model [131], which was modified for modeling responses to exter-
nal electric field stimulation, and to promote wavebreak and fibrillation, as previously
described [132–135]. Bidomain conductivities and Luo-Rudy model modifications are
given in Table A.1.
A.2.2 Numerical methods
Solutions to the bidomain and membrane equations were computed numerically
using the Cardiac Arrhythmia Research Package (CARP) [23]. To reduce the exten-
sive computation time required for these simulations, the CARP software was run in
parallel mode [23] on the IBM iDataPlex cluster at the Institute for Computational
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Table A.1: Computational model parameters used in rabbit heart
simulations.1
Description Parameter Value Units
Bidomain conductivities
Intracellular, longitudinal to fiber direction gil 1.74 mS/cm
Intracellular, transverse to fiber direction git 0.19 mS/cm
Extracellular, longitudinal to fiber direction gel 6.25 mS/cm
Extracellular, transverse to fiber direction get 2.38 mS/cm
Perfusing bath G0 0.80 mS/cm
Modified Luo-Rudy model parameters
Maximum fast Na+ current conductance ḡNa 16 mS/cm
2








ICa activation-gate (d) time constant
speed-up factor
1.5 -
ICa inactivation-gate (f) time constant
speed-up factor
1.5 -
1 From H. Tandri, S. H. Weinberg, K. C. Chang, R. Zhu, N. A. Trayanova, L. Tung, and
R. D. Berger, “Reversible cardiac conduction block and defibrillation with high-frequency
electric field.” Science translational medicine, vol. 3, no. 102, p. 102ra96, sep 2011. Reprinted
with permission from AAAS.
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Medicine at Johns Hopkins University. Details on the numerical techniques used by
CARP can be found elsewhere [24,48,136,137]. A time step of 20 µs was used.
A.2.3 Protocol for testing high-frequency
defibrillation
VF was induced using an S1-S2 protocol described previously [128]. Briefly, the
ventricles were paced from the apex to steady state at a cycle length (CL) of 300 ms,
and a 10-ms monophasic shock (9.3 V/cm, tilt= 62%) was delivered 200 ms after the
last paced beat across left and right plate electrodes. HFAC field pulses of varying
field strength were then delivered across the same plate electrodes at nine different
coupling intervals (CIs) after the S2 shock (500, 600, 750, 900, 1000, 1100, 1250, 1400,
and 1500 ms). Simulations were run for 500 ms after the end of the HFAC pulse.
A.2.4 Protocol for quantification of conduction block
VF was induced with a cross-stimulation protocol. The ventricles were paced from
the apex at basic CL of 300 ms, and then a 10-ms, 6-V/cm monophasic shock (62%
tilt) was applied 190 ms after the last paced beat, via parallel plate electrodes located
in the surrounding bath. Sinusoidal HFAC field pulses (50–500 Hz, 5–25 V/cm, 1 s)
were then delivered from plate electrodes at 11 different CIs following VF initiation
(500–1500 ms, in 100-ms intervals). After HFAC field pulse end, simulations were run
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for an additional 500 ms to assess defibrillation outcome. The VF termination rate
over all CIs was determined for each field strength and frequency combination.
A.2.5 Data analysis
We defined a conduction block metric as follows: transmembrane potential (Vm)
power spectrum at each node was calculated before and during the HFAC field by
Fast Fourier Transform. Vm power spectra before and during the field were computed
over 500-ms time windows ending at the time of field onset and offset, respectively.
Vm traces from the windows before and during the field are shown in red and blue,
respectively, in Figure A.2. Electrical conduction during both sinus rhythm and
fibrillation is typically in the range of 1–30 Hz. Therefore, the areas under the power
spectrum curve in the “conduction” frequency range of 1–30 Hz were computed for
time windows before and during the HFAC field. The loss of conduction power (LCP)
at each pixel was calculated as the percentage decrease in the conduction power during





For a given field strength and frequency, we defined two global values: 1) the aver-
age LCP and 2) the conduction block (CB) size. 1) LCP values were calculated at
each node as described above, and an average LCP value was computed for a given
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field strength and frequency by obtaining a weighted average over relevant nodes for
each CI (weighting each nodal value by the volumes of attached elements, see Sec-
tion A.2.6), and then averaging over all CIs. 2) CB was identified as occurring at site
where LCP was >90%. The size of CB regions was expressed as a percentage of the
total ventricular volume with LCP >90% (see Section A.2.6).
To investigate the effect of HFAC fields on CB location and LCP distribution, we
considered the fact that the majority of the Vm change induced by an external field
resulting from current entering the tissue is contained within one space constant [138].
Since the space constant in the direction transverse to cardiac fibers is approximately
300 µm [139], most of the field-induced surface polarization is contained within the
surface layer of elements in the model (average internodal distance of 507 µm). Thus,
we considered surface nodes, defined as nodes exposed to the external bath (consisting
of 24% of all nodes), separately from sub-surface (interior) nodes, defined as nodes
only connected to other tissue nodes (76%). Additionally, we analyzed the epicardial
and endocardial surface nodes separately.
A.2.6 Computing weighted averages
Since the computational mesh is composed of linear tetrahedral elements, average
Vm over a given volume may be computed by weighting the volume of each element
contained within the total volume by the average Vm of attached nodes, summing
the weighted volumes, and normalizing by the total volume. However, interpolation
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and integration of LCP over element volumes is not as straightforward, since LCP
is a nonlinear function of Vm. Therefore, in lieu of a true volume average, and since
segmentation of the mesh into surface and sub-surface regions was done by nodes
rather than by elements, we used a weighted average of nodal LCP values (weighted
by the volumes of attached elements and normalized by total counted volume) to












where S is the subset of nodes on either the surface or sub-surface, En is the subset of
elements connected to node n, LCPn is the LCP value at node n, and Ve is the volume
of element e. A global LCP value for each field strength and frequency combination
was then obtained by averaging over all CIs. CB size was calculated in the same
manner, except with nodal LCP values replaced by 1 or 0 for LCP> 90% or ≤ 90%,
respectively, and normalized as a percentage of the total number of nodes. CB size
is therefore a proxy measure for CB volume, as determination of the actual volume
would have required continuous interpolation and integration of LCP over the each
element. Nonetheless, our metric is an estimate that provides a basis for future
prediction and comparison.
The number of regions without conduction block was determined by separating
all nodes with LCP≤ 90% into groups of continuous nodes (see Fig.A.5). Each group
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was considered one region. The size of each region was determined using the same
weighted average formula as above, except with the nodal values replaced by 1 if a
node fell within the region and 0 otherwise, and this was summed over all nodes in
the mesh and normalized as a percentage of the total number of nodes.
A.2.7 Statistical methods
All summary values are expressed as mean ± standard error and compared using
the Student’s t test. Pearson’s correlation coefficient r was computed to assess linear
correlation. William’s formula was used to test for statistically significant differences
between dependent correlations [140]. For all tests, p < 0.05 was considered to be
significant.
A.3 Results
A.3.1 Conduction block and defibrillation by HFAC
We examined the effect of HFAC fields in the rabbit ventricular model (Fig. A.1A,
Section A.2.1), using the protocol described in Section A.2.3. Consistent with exper-
imental results [125], the model demonstrated that HFAC fields (25 V/cm) elevated
Vm (Fig. A.1B) and induced oscillations in Vm of opposite polarity at closely spaced
sites on the epicardial surface at the HFAC field frequency of 200 Hz (Fig. A.1C). This
129
APPENDIX A.
extinguished all pre-existing fibrillatory wavefronts, completely blocking propagation
in some tissue regions and evoking slow activity in other regions, perhaps because of
variable blockade of Na+ channels (Fig. A.1A). At the cellular level, in regions of con-
duction block, Vm, Ca
2+ current (ICa), K
+ current (IK), and intracellular Ca
2+ (Cai)
approached persistently elevated oscillating levels; whereas the Na+ current (INa) was
completely absent, coincident with the onset of the HFAC field at time 0 (Fig. A.1D).
Excitability is a post-shock property that depends on the amount of available
tissue with Vm below the Na
+ channel activation threshold. It affects the success
of a defibrillation shock [129, 141] and varies greatly during VF. During HFAC field
application, the amount of inexcitable tissue (tissue with Vm elevated above the Na
+
channel activation threshold) was maintained at an oscillating, elevated steady state
(Fig.A.1E), thereby reducing the likelihood of reinitiation of fibrillation after field
offset. Application of sufficiently strong HFAC fields successfully terminated VF 100%
of the time (9/9 different timings for HFAC field application) (Fig.A.1F). Although
the phase of application of HFAC was variable, termination was achieved in all the
trials using sufficient HFAC field, demonstrating that defibrillation success depends




Figure A.1: Computer simulation of HFAC field application in a bidomain
model of a rabbit heart2
A. Simulated transmembrane potential (Vm) map during a 200-Hz HFAC field
application at field offset (t= 1000 ms). B. Vm traces before, during (gray area),
and after HFAC field (25 V/cm). C. Vm traces from panel B at expanded time
scale to show oscillations at 200 Hz, with regions of opposite polarization. D. Na+
(INa), Ca
2+ (ICa), and delayed rectifier K
+ (IK) currents and intracellular Ca
2+
concentration (Cai) during HFAC field application. E. Percentage of inexcitable
tissue before, during (gray area), and after HFAC field (red trace). Trace for
a VF episode without HFAC field application (black) is also shown. Black and
red traces overlap before HFAC field. F. Defibrillation success rate, plotted as a
function of field strength for 200-Hz HFAC fields lasting 1 s.
2From H. Tandri, S. H. Weinberg, K. C. Chang, R. Zhu, N. A. Trayanova, L. Tung, and R. D.
Berger, “Reversible cardiac conduction block and defibrillation with high-frequency electric field.”




A.3.2 Degree and location of conduction block in
3D ventricles
We utilized simulations with an anatomically accurate model to assess CB in the
3D rabbit ventricles, both on the epicardial and endocardial surface, and in the in-
terior sub-surface regions. Protocols are described in Section A.2.4. In a simulation
of VF with an applied 200-Hz, 15-V/cm field (Fig. A.2), we observed that the HFAC
field only blocked conduction in some regions, i.e. incomplete CB. Consistent with
experiments, Vm traces in regions of CB (sites a and d) were elevated and oscillating
during HFAC with either no or small-amplitude activations, while areas of impeded
propagation (sites b, c, and e) had smaller Vm elevation and larger-amplitude activa-
tions (Fig.A.2A).
Spatial maps of LCP on the epicardial surface (Fig.A.2A, sites a and b) were
consistent with experiments [126], showing areas of high LCP values surrounding a
central region of lower values. A short-axis slice of the ventricles showed that larger
LCP values (>95%) were also observed over much of the endocardial surface, while
most of the sub-surface myocardium had a much lower LCP (Fig.A.2A, sites c–e).
Maps during failed defibrillation showed larger regions of low LCP values, especially
in interior regions (Fig A.2B).
We next calculated the multilinear regression for surface and sub-surface LCP and
VF termination. First, we found that sub-surface myocardial LCP was more closely
132
APPENDIX A.
correlated with VF termination (r=0.98, PVE=0.97, p < 10−13) than with surface
LCP (r=0.81, PVE=0.66, p < 10−4; the difference between correlations was also
significant, p < 10−5) (Fig.A.3). We found similar correlation values between surface
LCP and VF termination as in optical mapping experiments of isolated hearts [126]
(p = 0.68, not significantly different). These findings demonstrate that while both
surface and sub-surface LCP were correlated with defibrillation success, LCP in the
sub-surface myocardium was a better predictor of defibrillation success compared with
LCP in the surface myocardium.
We additionally analyzed average LCP from the epicardial and endocardial sur-
faces separately. Mean values for the endocardial LCP are in general slightly smaller
than the epicardial LCP, although the values are very close and the linear regression
curves are almost the same (Fig. A.4, green and black circles, dotted lines). These
results justify the collective analysis of the surface LCP values, as opposed to sepa-
rate consideration of the epicardial and endocardial surfaces, and are consistent with
sub-surface LCP as the best predictor of defibrillation success.
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Figure A.2: Conduction block on the surface and sub-surface myocardium dur-
ing HFAC fields3
A. Successful and B. failed termination of ventricular fibrillation (VF). Spatial
maps of loss of conduction power (LCP) on (left) the epicardial surface and (mid-
dle) a short-axis slice. (Right) Vm traces at sites a–e, shown in the spatial maps
in panel A, with corresponding LCP values. Grey bar indicates time of the HFAC
field. The time windows used for LCP analysis before and during the HFAC field
are shown in red and blue, respectively.
3Reprinted from S. H. Weinberg, K. C. Chang, R. Zhu, H. Tandri, R. D. Berger, N. A. Trayanova,
and L. Tung, “Defibrillation success with high frequency electric fields is related to degree and




Figure A.3: Surface and sub-surface conduction block and ventricular fibrilla-
tion vulnerability4
A. Percentage of simulations terminating ventricular fibrillation (VF), B. average
(a) surface and (b) sub-surface loss of conduction power (LCP) values, and C.
average (a) surface and (b) sub-surface conduction block (CB) size, as a function
of field frequency and voltage. Correlation between D. average loss of conduction
power (LCP) or E. CB size on the surface (red) or sub-surface (blue) myocardium
and the percentage of simulations terminating VF.
4Reprinted from S. H. Weinberg, K. C. Chang, R. Zhu, H. Tandri, R. D. Berger, N. A. Trayanova,
and L. Tung, “Defibrillation success with high frequency electric fields is related to degree and




Figure A.4: Relationships between average epicardial, endocardial and sub-
surface loss of conduction power and ventricular fibrillation termination5
Correlation between the percentage of simulations terminating ventricular fibril-
lation (VF) and average loss of conduction power (LCP) in the epicardial (green),
endocardial (black), and sub-surface (blue) myocardium.
A.3.3 Coupling and size of regions without
conduction block in simulations
The simulations suggested that HFAC fields terminate arrhythmias by isolating
regions in the sub-surface myocardial tissue without CB, thereby preventing reentrant
waves from continuing after the applied field offset. To assess the field effect, we
quantified the average number and size of regions without CB, as a function of field
strength and frequency (Fig.A.5A). The uncoupling of these regions, as well as their
5Reprinted from S. H. Weinberg, K. C. Chang, R. Zhu, H. Tandri, R. D. Berger, N. A. Trayanova,
and L. Tung, “Defibrillation success with high frequency electric fields is related to degree and




Figure A.5: Coupling and size of regions without conduction block6
A. Average number and size of regions without conduction block (CB) as a func-
tion of field strength and frequency. B. Correlation between the average number
and size of regions without CB and the percentage of simulations terminating
ventricular fibrillation (VF).
size, depended greatly on field parameters. In general, at high field frequencies and
low field strengths, there were fewer regions, but they were larger in size. As frequency
decreased, these regions decreased in size, because total CB volume increased and
because more regions became uncoupled from the main large compartment, resulting
in a greater number of regions. Similar trends occurred as field strength increased,
except that for 50-Hz HFAC fields, the number of regions decreased as field strength
increased above 10 V/cm. This was due to the fact that smaller regions eventually
disappeared as areas of CB expanded.
6Reprinted from S. H. Weinberg, K. C. Chang, R. Zhu, H. Tandri, R. D. Berger, N. A. Trayanova,
and L. Tung, “Defibrillation success with high frequency electric fields is related to degree and




These trends were correlated with rates of successful defibrillation. Reentry dur-
ing HFAC field was difficult to track in the simulations, as propagation arose from
both preexisting reentrant wavefronts and from new activations occurring as a result
of virtual electrode polarization (VEP). However, regardless of the source, defibrilla-
tion success increased as the total volume of block increased (Fig.A.3), and as the
remaining tissue without CB became increasingly uncoupled into a larger number
of smaller compartments (Fig.A.5B, r=0.83 correlation between percentage of VF
termination with number of regions; r=−0.96, size of regions). This suggests that
successful HFAC fields defibrillate by surrounding sufficiently small excitable areas
with regions of block, essentially “trapping” wavefronts and preventing them from
“escaping” and initiating reentry.
A.4 Conclusion
HFAC fields terminate VF by maintaining Vm at an elevated, depolarized level that
inactivates Na+ channels and blocks conduction. Defibrillation success depends on
the degree of conduction block on both the surface and sub-surface myocardium, and




[1] G. Tomaselli, “Electrophysiological remodeling in hypertrophy and heart fail-
ure,” Cardiovascular Research, vol. 42, no. 2, pp. 270–283, may 1999.
[2] D. M. Bers, “Cardiac excitation–contraction coupling,” Nature, vol. 415, no.
6868, pp. 198–205, jan 2002.
[3] Z. Qu, J. N. Weiss, and A. Garfinkel, “Cardiac electrical restitution properties
and stability of reentrant spiral waves: a simulation study,” Am J Physiol Heart
Circ Physiol, vol. 276, no. 1, pp. H269–283, 1999.
[4] S. M. Narayan, “T-wave alternans and the susceptibility to ventricular arrhyth-
mias.” Journal of the American College of Cardiology, vol. 47, no. 2, pp. 269–81,
jan 2006.
[5] S. M. Narayan, J. D. Bayer, G. Lalani, and N. A. Trayanova, “Action Potential
Dynamics Explain Arrhythmic Vulnerability in Human Heart Failure. A Clinical
and Modeling Study Implicating Abnormal Calcium Handling,” Journal of the
American College of Cardiology, vol. 52, no. 22, pp. 1782–1792, nov 2008.
[6] J. B. Nolasco and R. W. Dahlen, “A graphic method for the study of alternation
in cardiac action potentials.” Journal of applied physiology, vol. 25, no. 2, pp.
191–6, aug 1968.
[7] J. N. Weiss, A. Karma, Y. Shiferaw, P. S. Chen, A. Garfinkel, and Z. Qu,
“From pulsus to pulseless: The saga of cardiac alternans,” Circulation Research,
vol. 98, no. 10, pp. 1244–1253, may 2006.
[8] L. Wang, R. C. Myles, N. M. De Jesus, A. K. P. Ohlendorf, D. M. Bers, and
C. M. Ripplinger, “Optical mapping of sarcoplasmic reticulum Ca2+ in the in-
tact heart: Ryanodine receptor refractoriness during alternans and fibrillation,”
Circulation Research, vol. 114, no. 9, pp. 1410–1421, feb 2014.
139
BIBLIOGRAPHY
[9] M. A. Watanabe, F. H. Fenton, S. J. Evans, H. M. Hastings, and A. Karma,
“Mechanisms for discordant alternans.” Journal of Cardiovascular Electrophys-
iology, vol. 12, no. 2, pp. 196–206, feb 2001.
[10] S. S. Chugh, R. Havmoeller, K. Narayanan, D. Singh, M. Rienstra, E. J. Ben-
jamin, R. F. Gillum, Y.-H. Kim, J. H. McAnulty, Z.-J. Zheng, M. H. Forouzan-
far, M. Naghavi, G. A. Mensah, M. Ezzati, and C. J. L. Murray, “Worldwide
Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study,”
Circulation, vol. 129, no. 8, pp. 837–847, feb 2014.
[11] L. Fabritz, E. Guasch, C. Antoniades, I. Bardinet, G. Benninger, T. R. Betts,
E. Brand, G. Breithardt, G. Bucklar-Suchankova, A. J. Camm, D. Cartlidge,
B. Casadei, W. W. L. Chua, H. J. G. M. Crijns, J. Deeks, S. Hatem, F. Hidden-
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ALTfast human atria model with alternans onset at fast rates
ALTslow human atria model with alternans onset at slow rates
ANM APD alternans normalized magnitude
AP action potential
APD action potential duration
AVN atrioventricular node
cAF chronic AF















GPV Grandi-Pandit-Voigt human atrial action potential model
GPVm modified GPV model
JSR junctional sarcoplasmic reticulum
LA left atrium
LRd Luo-Rudy dynamic model
LV left ventricle
NCX Na+/Ca2+ exchanger


















IK1 inward rectifier K
+ current
IKr delayed rectifier K
+ current
INCXsl sub-sarcolemmal Na








Ito transient outward K
+ current




Kmf Km for SERCA pump in forward mode
RyRi RyR2 inactivated probability
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SYMBOLS
RyRo RyR2 open probability
Vm transmembrane potential
VmaxSRCaP Vmax of SERCA pump
∆[Ca2+]i intracellular Ca
2+ transient amplitude
ĪNCX maximal NCX current
ḡCaL maximum L-type Ca
2+ current conductance
ḡK1 maximum inward rectifier K
+ current conductance
ḡKr maximum delayed rectifier K
+ current conductance
ḡKs maximum slowly activating delayed rectifier K
+ current conductance
ḡKur maximum ultra-rapid delayed rectifier K
+ current conductance
ḡNaL maximum late Na
+ current conductance
ḡNa maximum fast Na
+ current conductance
ḡto maximum transient outward K
+ current conductance
κ sarcolemmal Ca2+ efflux factor
τf L-type Ca
2+ current voltage-dependent inactivation time constant
τfCa L-type Ca
2+ current Ca2+-dependent inactivation time constant
ec50SR EC50 for luminal Ca
2+ dependence of RyR2
kleak SR Ca
2+ leak rate constant
ks SR Ca
2+ release rate constant
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SYMBOLS
kiCa RyR2 inactivation rate constant
kim transition rate constant for RyR2
koCa RyR2 activation rate constant
kom transition rate constant for RyR2
m SR Ca2+ release slope
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